{
  "conditions_to_closing": [
    {
      "section": "conditions_to_closing",
      "field_name": "mutual_conditions_list",
      "answer": [
        "The Company shall have obtained the Company Stockholder Approval.",
        "The Parent Share Issuance shall have been approved for listing on the NYSE, subject to official notice of issuance.",
        "The Form F-4 shall have become effective under the Securities Act and shall not be the subject of any stop order or any Proceedings by or before the SEC seeking a stop order.",
        "Any applicable waiting period (and any extension thereof) under the HSR Act relating to the consummation of the Merger shall have expired or early termination thereof shall have been granted (the 'Required Regulatory Approval').",
        "No Governmental Authority of competent jurisdiction shall have issued or entered any Order after the date of this Agreement, and no Law shall have been enacted or promulgated after the date of this Agreement, in each case, that (whether temporary or permanent) is then in effect and has the effect of enjoining or otherwise prohibiting the consummation of the Merger (a 'Restraint')."
      ],
      "summary": "The mutual conditions for closing include obtaining stockholder approval, NYSE listing approval, Form F-4 effectiveness, expiration of HSR Act waiting period, and absence of legal prohibitions.",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "The respective obligations of each party to consummate the Merger are subject to the satisfaction or (to the extent permitted by Law) waiver by the Company and Parent at or prior to the Closing of the following conditions: (a) the Company shall have obtained the Company Stockholder Approval; (b) the Parent Share Issuance shall have been approved for listing on the NYSE, subject to official notice of issuance; (c) the Form F-4 shall have become effective under the Securities Act and shall not be the subject of any stop order or any Proceedings by or before the SEC seeking a stop order; (d) any applicable waiting period (and any extension thereof) under the HSR Act relating to the consummation of the Merger shall have expired or early termination thereof shall have been granted (the 'Required Regulatory Approval'); and (e) no Governmental Authority of competent jurisdiction shall have issued or entered any Order after the date of this Agreement, and no Law shall have been enacted or promulgated after the date of this Agreement, in each case, that (whether temporary or permanent) is then in effect and has the effect of enjoining or otherwise prohibiting the consummation of the Merger (a 'Restraint').",
      "reference_section": "ARTICLE Article VI CONDITIONS TO THE MERGER > Section 6.1 Conditions to the Obligations of Each Party"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "parent_closing_conditions",
      "answer": [
        "Each of the representations and warranties of the Company contained in specified sections shall be true and correct in all respects as of the Closing Date, except for de minimis inaccuracies.",
        "The Company Fundamental Representations shall be true and correct in all material respects as of the Closing Date.",
        "Other representations and warranties of the Company shall be true and correct as of the Closing Date, except where failure to be true and correct has not had a Material Adverse Effect on the Company.",
        "The Company shall have performed or complied in all material respects with its obligations required under the Agreement to be performed or complied with on or prior to the Closing.",
        "Since the date of the Agreement, there shall not have been any event that has had a Material Adverse Effect on the Company.",
        "Parent shall have received a certificate signed by an executive officer of the Company certifying as to the matters set forth in the specified sections."
      ],
      "summary": "The obligations of Parent and Merger Sub to effect the Merger are subject to conditions including the accuracy of the Company's representations, performance of obligations, absence of a Material Adverse Effect, and receipt of a certification from the Company.",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "The obligations of Parent and Merger Sub to effect the Merger are subject to the satisfaction or (to the extent permitted by Law) waiver by Parent at or prior to the Closing of the following additional conditions: (a) each of the representations and warranties of the Company... shall be true and correct... (b) the Company shall have performed or complied in all material respects... (c) since the date of this Agreement, there shall not have been any event... (d) Parent shall have received a certificate signed by an executive officer of the Company...",
      "reference_section": "ARTICLE VI – CONDITIONS TO THE MERGER > Section 6.2 Conditions to Obligations of Parent and Merger Sub to Effect the Merger"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "company_closing_conditions",
      "answer": [
        "Each of the representations and warranties of Parent and Merger Sub contained in specified sections shall be true and correct in all respects or in all material respects as of the Closing Date.",
        "Parent and Merger Sub shall have performed or complied in all material respects with each of their respective obligations required under the Agreement to be performed or complied with on or prior to the Closing.",
        "Since the date of the Agreement, there shall not have been any event, circumstance, occurrence, effect, fact, development or change that has had, or would reasonably be expected to have, a Material Adverse Effect on Parent.",
        "The Company shall have received a certificate signed by an executive officer of Parent certifying as to the matters set forth in the specified sections."
      ],
      "summary": "The Company must ensure the accuracy of Parent's representations, compliance with obligations, absence of material adverse effects, and receipt of a certification from Parent.",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "The obligation of the Company to effect the Merger is subject to the satisfaction or (to the extent permitted by Law) waiver by the Company at or prior to the Closing of the following additional conditions: (a) each of the representations and warranties of Parent and Merger Sub... shall be true and correct... (b) Parent and Merger Sub shall have performed or complied... (c) since the date of this Agreement there shall not have been any event... (d) the Company shall have received a certificate signed by an executive officer of Parent...",
      "reference_section": "ARTICLE Article VI CONDITIONS TO THE MERGER > Section 6.3 Conditions to Obligation of the Company to Effect the Merger"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "target_shareholder_approval_required",
      "answer": true,
      "summary": "",
      "confidence": 1.0,
      "reason": "The agreement explicitly states that the Company must obtain the Company Stockholder Approval as a condition to closing.",
      "clause_text": "The respective obligations of each party to consummate the Merger are subject to the satisfaction or (to the extent permitted by Law) waiver by the Company and Parent at or prior to the Closing of the following conditions: (a) the Company shall have obtained the Company Stockholder Approval;",
      "reference_section": "ARTICLE VI – CONDITIONS TO THE MERGER > Section 6.1 Conditions to the Obligations of Each Party"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "target_shareholder_approval_threshold",
      "answer": "majority of the outstanding shares of Company Common Stock entitled to vote thereon",
      "summary": "The adoption of the Agreement requires the affirmative vote of at least a majority of the outstanding shares of Company Common Stock entitled to vote.",
      "confidence": 1.0,
      "reason": "The document explicitly states the threshold for shareholder approval as a majority of the outstanding shares.",
      "clause_text": "Assuming the accuracy of Parent's and Merger Sub's representations and warranties in Section 4.24, the adoption of this Agreement by the affirmative vote of the holders of at least a majority of the outstanding shares of Company Common Stock entitled to vote thereon at the Company Stockholders' Meeting (the \"Company Stockholder Approval\") is the only vote of holders of securities of the Company that is required in connection with the consummation by the Company of the transactions contemplated by this Agreement;",
      "reference_section": "ARTICLE III – Representations and Warranties of the Company > Section 3.4 Vote Required"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "hsr_clearance_required",
      "answer": true,
      "summary": "",
      "confidence": 1.0,
      "reason": "The agreement explicitly states that the expiration or early termination of the waiting period under the HSR Act is a condition to closing the merger.",
      "clause_text": "any applicable waiting period (and any extension thereof) under the HSR Act relating to the consummation of the Merger shall have expired or early termination thereof shall have been granted (the 'Required Regulatory Approval');",
      "reference_section": "ARTICLE VI CONDITIONS TO THE MERGER > Section 6.1 Conditions to the Obligations of Each Party"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "other_customary_conditions",
      "answer": [
        "Company Stockholder Approval obtained",
        "Parent Share Issuance approved for listing on the NYSE",
        "Form F-4 effective under the Securities Act",
        "Expiration or early termination of any applicable waiting period under the HSR Act",
        "No Governmental Authority issued an Order prohibiting the Merger"
      ],
      "summary": "The customary conditions to closing include obtaining Company Stockholder Approval, approval for listing on the NYSE, effectiveness of Form F-4, expiration of HSR Act waiting periods, and absence of governmental orders prohibiting the merger.",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "The respective obligations of each party to consummate the Merger are subject to the satisfaction or (to the extent permitted by Law) waiver by the Company and Parent at or prior to the Closing of the following conditions: (a) the Company shall have obtained the Company Stockholder Approval; (b) the Parent Share Issuance shall have been approved for listing on the NYSE, subject to official notice of issuance; (c) the Form F-4 shall have become effective under the Securities Act and shall not be the subject of any stop order or any Proceedings by or before the SEC seeking a stop order; (d) any applicable waiting period (and any extension thereof) under the HSR Act relating to the consummation of the Merger shall have expired or early termination thereof shall have been granted (the \"Required Regulatory Approval\"); and (e) no Governmental Authority of competent jurisdiction shall have issued or entered any Order after the date of this Agreement, and no Law shall have been enacted or promulgated after the date of this Agreement, in each case, that (whether temporary or permanent) is then in effect and has the effect of enjoining or otherwise prohibiting the consummation of the Merger (a \"Restraint\").",
      "reference_section": "ARTICLE VI – CONDITIONS TO THE MERGER > Section 6.1 Conditions to the Obligations of Each Party"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_minimum_cash_threshold",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_maximum_net_debt",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_minimum_any_condition",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "tax_conditions_tax_opinion_required",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    }
  ],
  "material_adverse_effect": {
    "mae_carveout": [
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_general_economic_conditions_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes adverse effects resulting from actions taken at the express written request of the Parent.",
        "clause_text": "any action taken or (to the extent the relevant action is expressly permitted by the terms of this Agreement) not taken at the express written request of the Company (in the case of Parent) or Parent (in the case of the Company) after the date of this Agreement;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_general_economic_conditions_explanation",
        "answer": "Adverse effects resulting from general economic conditions are excluded from the definition of Material Adverse Effect.",
        "summary": "Adverse effects resulting from general economic conditions are excluded from the definition of Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: (i) changes in general economic, financial market, regulatory, business, financial, political, geopolitical, credit or capital market conditions, including interest or exchange rates, tariffs and trade wars;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_industry_conditions_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes general changes or developments in any of the industries or markets in which the Company operates from constituting a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: (ii) general changes or developments in any of the industries or markets in which such Person or any of its Subsidiaries operate;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_industry_conditions_explanation",
        "answer": "changes in general economic, financial market, regulatory, business, financial, political, geopolitical, credit or capital market conditions, including interest or exchange rates, tariffs and trade wars; (ii) general changes or developments in any of the industries or markets in which such Person or any of its Subsidiaries operate;",
        "summary": "The MAE definition excludes general changes or developments in the industries or markets in which the Company operates from being considered a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: (i) changes in general economic, financial market, regulatory, business, financial, political, geopolitical, credit or capital market conditions, including interest or exchange rates, tariffs and trade wars; (ii) general changes or developments in any of the industries or markets in which such Person or any of its Subsidiaries operate;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_stock_price_changes_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes changes in the price or trading volume of the Company's securities from constituting a Material Adverse Effect.",
        "clause_text": "any change in the price or trading volume of such Person's securities or other financial instruments or change in such Person's credit rating, in and of itself (provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_stock_price_changes_explanation",
        "answer": "changes in the price or trading volume of such Person's securities or other financial instruments or change in such Person's credit rating, in and of itself (provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred)",
        "summary": "The clause excludes changes in the price or trading volume of the Company's securities from the Material Adverse Effect definition, unless such changes are due to underlying facts not otherwise excluded.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "any change in the price or trading volume of such Person's securities or other financial instruments or change in such Person's credit rating, in and of itself (provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred)",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_credit_rating_changes_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes changes in credit ratings from constituting a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: ... (iv) any change in the price or trading volume of such Person's securities or other financial instruments or change in such Person's credit rating, in and of itself ...",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_credit_rating_changes_explanation",
        "answer": "Changes in credit ratings are excluded from the definition of Material Adverse Effect.",
        "summary": "The clause explicitly states that any change in the credit rating of a Person, in and of itself, shall not constitute a Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause specifically excludes changes in credit ratings from being considered a Material Adverse Effect.",
        "clause_text": "any change in the price or trading volume of such Person's securities or other financial instruments or change in such Person's credit rating, in and of itself (provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_legal_or_regulatory_changes_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes changes in laws, regulations, GAAP, or accounting principles from constituting a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: ... (iii) (A) adoption, implementation, repeal, modification or amendment of any applicable Laws or (B) changes in GAAP, ...",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_legal_or_regulatory_changes_explanation",
        "answer": "changes in laws, regulations, GAAP, or accounting principles are excluded from the MAE definition",
        "summary": "The clause excludes changes in laws, regulations, GAAP, or accounting principles from the definition of Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that changes in laws, regulations, GAAP, or accounting principles are not to be considered in determining a Material Adverse Effect.",
        "clause_text": "provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: ... (iii) (A) adoption, implementation, repeal, modification or amendment of any applicable Laws or (B) changes in GAAP, or in the case of each of clause (A) and (B), any proposal therefor or change in interpretations or enforcement thereof;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_force_majeure_events_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes acts of God, natural disasters, and weather-related events from constituting a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean... provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred:... (vi) acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing, weather related events, fires, natural disasters, epidemics, pandemics, plagues or other outbreaks of illness or disease or public health events (including COVID-19) or any other acts of God;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_force_majeure_events_explanation",
        "answer": "Acts of God, natural disasters, and weather-related events are excluded from the definition of Material Adverse Effect.",
        "summary": "The definition of Material Adverse Effect excludes acts of God, natural disasters, and weather-related events such as hurricanes, earthquakes, floods, and wildfires.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that weather-related events, natural disasters, and acts of God are not considered a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean... provided that none of the following... shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred:... (vi) acts of war... weather related events, fires, natural disasters, epidemics, pandemics, plagues or other outbreaks of illness or disease or public health events (including COVID-19) or any other acts of God;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_political_events_or_war_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes acts of war, terrorism, military actions, or acts of terrorism from constituting a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: ... (vi) acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing, ...",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_political_events_or_war_explanation",
        "answer": "acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing",
        "summary": "The clause excludes acts of war, hostilities, military actions, terrorism, and cyberterrorism from the Material Adverse Effect definition.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_pandemic_health_events_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes pandemics, epidemics, or public health emergencies, including COVID-19, from constituting a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean... provided that none of the following... shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred:... (vi) acts of war... epidemics, pandemics, plagues or other outbreaks of illness or disease or public health events (including COVID-19)...",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_pandemic_health_events_explanation",
        "answer": "epidemics, pandemics, plagues or other outbreaks of illness or disease or public health events (including COVID-19) shall not constitute a Material Adverse Effect",
        "summary": "The clause explicitly states that epidemics, pandemics, plagues, or other outbreaks of illness or disease, including COVID-19, are excluded from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: ... (vi) acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing, weather related events, fires, natural disasters, epidemics, pandemics, plagues or other outbreaks of illness or disease or public health events (including COVID-19) or any other acts of God;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_agreement_compliance_effects_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes effects resulting from the execution of the Agreement, the public announcement, pendency, or consummation of the Merger from constituting a Material Adverse Effect.",
        "clause_text": "the execution of this Agreement, the public announcement, pendency or consummation of the Merger or the other transactions contemplated by this Agreement (including, to the extent resulting from the foregoing, any effect on any of such Person’s or any of its Subsidiaries’ relationships with their respective customers, suppliers or employees);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_agreement_compliance_effects_explanation",
        "answer": "The effects resulting from the negotiation, execution, or announcement of the merger agreement are excluded from the MAE definition.",
        "summary": "The execution of this Agreement, the public announcement, pendency or consummation of the Merger or the other transactions contemplated by this Agreement are excluded from the MAE definition.",
        "confidence": 0.9,
        "reason": "The clause explicitly excludes the execution, announcement, and consummation of the merger from being considered a Material Adverse Effect.",
        "clause_text": "the execution of this Agreement, the public announcement, pendency or consummation of the Merger or the other transactions contemplated by this Agreement (including, to the extent resulting from the foregoing, any effect on any of such Person’s or any of its Subsidiaries’ relationships with their respective customers, suppliers or employees);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_parent_actions_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition includes a carve-out for actions taken at the express written request of the Company.",
        "clause_text": "any action taken or (to the extent the relevant action is expressly permitted by the terms of this Agreement) not taken at the express written request of the Company (in the case of Parent) or Parent (in the case of the Company) after the date of this Agreement;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_parent_actions_explanation",
        "answer": "Adverse effects resulting from actions taken by the Company at the direction, request, or with the consent of the Parent are excluded from the definition of Material Adverse Effect.",
        "summary": "The definition of Material Adverse Effect excludes any action taken or not taken at the express written request of the Parent.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that actions taken at the express written request of the Parent are excluded from being considered a Material Adverse Effect.",
        "clause_text": "any action taken or (to the extent the relevant action is expressly permitted by the terms of this Agreement) not taken at the express written request of the Company (in the case of Parent) or Parent (in the case of the Company) after the date of this Agreement;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_projections_miss_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes failures to meet projections, forecasts, estimates, or internal budgets from constituting a Material Adverse Effect.",
        "clause_text": "any failure by such Person to meet its internal or published projections, budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operation or any published analyst or other third-party estimates or expectations of such Person's revenue, earnings or other financial performance or results of operations for any period, in and of itself (provided that the facts or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_projections_miss_explanation",
        "answer": "Failures to meet projections, forecasts, estimates, or internal budgets are excluded from the MAE definition.",
        "summary": "The clause explicitly states that any failure by a person to meet its internal or published projections, budgets, plans, or forecasts of its revenues, earnings, or other financial performance or results of operation shall not constitute a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly excludes failures to meet projections from being considered a Material Adverse Effect.",
        "clause_text": "any failure by such Person to meet its internal or published projections, budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operation or any published analyst or other third-party estimates or expectations of such Person's revenue, earnings or other financial performance or results of operations for any period, in and of itself (provided that the facts or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_other_custom_items_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The provided MAE clause does not include any carve-outs beyond the standard exclusions listed.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: (i) changes in general economic, financial market, regulatory, business, financial, political, geopolitical, credit or capital market conditions, including interest or exchange rates, tariffs and trade wars; (ii) general changes or developments in any of the industries or markets in which such Person or any of its Subsidiaries operate; (iii) (A) adoption, implementation, repeal, modification or amendment of any applicable Laws or (B) changes in GAAP, or in the case of each of clause (A) and (B), any proposal therefor or change in interpretations or enforcement thereof; (iv) any change in the price or trading volume of such Person's securities or other financial instruments or change in such Person's credit rating, in and of itself (provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred); (v) any failure by such Person to meet its internal or published projections, budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operation or any published analyst or other third-party estimates or expectations of such Person's revenue, earnings or other financial performance or results of operations for any period, in and of itself (provided that the facts or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred); (vi) acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing, weather related events, fires, natural disasters, epidemics, pandemics, plagues or other outbreaks of illness or disease or public health events (including COVID-19) or any other acts of God; (vii) any action taken or (to the extent the relevant action is expressly permitted by the terms of this Agreement) not taken at the express written request of the Company (in the case of Parent) or Parent (in the case of the Company) after the date of this Agreement; (viii) the identity of Company (in the case of Parent) or Parent (in the case of the Company) and, other than with respect to a representation or warranty contained in this Agreement to the extent that the purpose of such representation or warranty is to address the consequences resulting from the execution and delivery of this Agreement or the consummation of the Merger or the performance of obligations under this Agreement, the execution of this Agreement, the public announcement, pendency or consummation of the Merger or the other transactions contemplated by this Agreement (including, to the extent resulting from the foregoing, any effect on any of such Person’s or any of its Subsidiaries’ relationships with their respective customers, suppliers or employees); or (ix) any matter disclosed against a representation or warranty set forth in Article III in the Company Disclosure Letter (as it relates to the Company) or Article IV in the Parent Disclosure Letter in (as it relates to Parent); provided, further, that, the exceptions in clauses (i) through (iii) and (vi) shall not apply to the extent the events, circumstances, occurrences, effects, facts, developments or changes set forth in such clauses have a disproportionate impact on such Person and its Subsidiaries, taken as a whole, relative to the other participants in the industries in which such Person and its Subsidiaries operate.",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_other_custom_items",
        "answer": [
          {
            "label": "Identity of Parties",
            "excerpt": "the identity of Company (in the case of Parent) or Parent (in the case of the Company) and, other than with respect to a representation or warranty contained in this Agreement to the extent that the purpose of such representation or warranty is to address the consequences resulting from the execution and delivery of this Agreement or the consummation of the Merger or the performance of obligations under this Agreement, the execution of this Agreement, the public announcement, pendency or consummation of the Merger or the other transactions contemplated by this Agreement (including, to the extent resulting from the foregoing, any effect on any of such Person’s or any of its Subsidiaries’ relationships with their respective customers, suppliers or employees)"
          },
          {
            "label": "Disclosed Matters",
            "excerpt": "any matter disclosed against a representation or warranty set forth in Article III in the Company Disclosure Letter (as it relates to the Company) or Article IV in the Parent Disclosure Letter in (as it relates to Parent)"
          }
        ],
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "mae_carveback": [
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_disproportionate_effects_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE clause specifies that carve-outs are reintroduced if the Company is disproportionately affected compared to others in its industry.",
        "clause_text": "provided, further, that, the exceptions in clauses (i) through (iii) and (vi) shall not apply to the extent the events, circumstances, occurrences, effects, facts, developments or changes set forth in such clauses have a disproportionate impact on such Person and its Subsidiaries, taken as a whole, relative to the other participants in the industries in which such Person and its Subsidiaries operate.",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_disproportionate_effects_explanation",
        "answer": "disproportionate impact",
        "summary": "The MAE definition includes a carve-back stating that certain carve-outs do not apply if the events have a disproportionate impact on the Company or Parent relative to others in its industry.",
        "confidence": 0.95,
        "reason": "The clause explicitly mentions that exceptions do not apply if events have a disproportionate impact on the entity relative to industry participants.",
        "clause_text": "provided, further, that, the exceptions in clauses (i) through (iii) and (vi) shall not apply to the extent the events, circumstances, occurrences, effects, facts, developments or changes set forth in such clauses have a disproportionate impact on such Person and its Subsidiaries, taken as a whole, relative to the other participants in the industries in which such Person and its Subsidiaries operate.",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_additional_exceptions_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE clause includes carve-back language specifying that exceptions do not apply if the events have a disproportionate impact on the company.",
        "clause_text": "provided, further, that, the exceptions in clauses (i) through (iii) and (vi) shall not apply to the extent the events, circumstances, occurrences, effects, facts, developments or changes set forth in such clauses have a disproportionate impact on such Person and its Subsidiaries, taken as a whole, relative to the other participants in the industries in which such Person and its Subsidiaries operate.",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_additional_exceptions_explanation",
        "answer": [
          "The exceptions in clauses (i) through (iii) and (vi) shall not apply to the extent the events, circumstances, occurrences, effects, facts, developments or changes set forth in such clauses have a disproportionate impact on such Person and its Subsidiaries, taken as a whole, relative to the other participants in the industries in which such Person and its Subsidiaries operate."
        ],
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_causation_based_analysis_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition includes language indicating that the underlying facts or occurrences giving rise to changes in stock price or failures to meet projections may be considered in determining a Material Adverse Effect.",
        "clause_text": "provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_causation_based_analysis_explanation",
        "answer": "The facts or occurrences giving rise to an excluded event may still be taken into account in determining whether a Material Adverse Effect has occurred, specifically for changes in the price or trading volume of securities and failures to meet projections.",
        "summary": "The carve-back allows for the consideration of underlying facts or occurrences that contribute to changes in securities prices or failures to meet projections when assessing a Material Adverse Effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that facts or occurrences contributing to changes in securities prices or failures to meet projections may be considered.",
        "clause_text": "provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred",
        "reference_section": "Definition > Material Adverse Effect"
      }
    ]
  },
  "non_solicitation": {
    "no_shop_clause": [
      {
        "section": "non_solicitation",
        "field_name": "no_shop_clause_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement includes a 'No-Shop' clause as it explicitly restricts the Company from soliciting or engaging in discussions regarding alternative acquisition proposals.",
        "clause_text": "the Company shall not, and shall not authorize, and shall use its reasonable best efforts not to permit, any of its Representatives to, directly or indirectly through another Person, (A) initiate, seek, solicit, knowingly facilitate, knowingly encourage (including by way of furnishing any non-public information) or knowingly induce or knowingly take any other action which would reasonably be expected to lead to an Acquisition Proposal.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (a)"
      },
      {
        "section": "non_solicitation",
        "field_name": "no_shop_claus_explanation",
        "answer": "The Company is restricted from soliciting, initiating, or encouraging competing acquisition proposals and must cease all existing discussions, negotiations, and communications with any third parties regarding any Acquisition Proposal, except as provided in specific sections.",
        "summary": "The Company is restricted from soliciting, initiating, or encouraging competing acquisition proposals and must cease all existing discussions, negotiations, and communications with any third parties regarding any Acquisition Proposal, except as provided in specific sections.",
        "confidence": 0.95,
        "reason": "The clause explicitly prohibits the Company from engaging in activities that would lead to an Acquisition Proposal.",
        "clause_text": "From the date of this Agreement until the earlier of the Effective Time and the termination of this Agreement in accordance with Section 7.1, except as provided in Section 5.6(b) or Section 5.6(d), (i) the Company shall, and shall cause its Subsidiaries, and its and their respective officers and directors to, immediately cease, and shall instruct and use its reasonable best efforts to cause its and their respective other Representatives to immediately cease, and cause to be terminated all existing discussions, negotiations and communications with any Persons or entities with respect to any Acquisition Proposal (other than the transactions contemplated by this Agreement), (ii) the Company shall not, and shall not authorize, and shall use its reasonable best efforts not to permit, any of its Representatives to, directly or indirectly through another Person, (A) initiate, seek, solicit, knowingly facilitate, knowingly encourage (including by way of furnishing any non-public information) or knowingly induce or knowingly take any other action which would reasonably be expected to lead to an Acquisition Proposal, (B) engage in negotiations or discussions with, or provide any non-public information or non-public data to, any Person (other than Parent or any of its Representatives) relating to or for the purpose of encouraging or facilitating, any Acquisition Proposal or grant any waiver or release under any standstill, confidentiality or other similar agreement (except that if the Company Board determines in good faith that the failure to grant any waiver or release would be inconsistent with its fiduciary duties under applicable Law, the Company may waive any such standstill provision in order to permit a third party to make and pursue an Acquisition Proposal) or (C) resolve to do any of the foregoing, (iii) the Company shall not provide and shall, within one (1) Business Day of the date of this Agreement, terminate access of any third party to any data room (virtual or actual) which has been set up in the context of a possible Acquisition Proposal containing any information of the Company or any of its Subsidiaries and (iv) within one (1) Business Day of the date of this Agreement, the Company shall demand the return or destruction of all confidential, non-public information and materials that have been provided to third parties that have entered into confidentiality agreements relating to a possible Acquisition Proposal with the Company or any of its Subsidiaries.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (a)"
      }
    ],
    "notice_of_competing_offer": [
      {
        "section": "non_solicitation",
        "field_name": "notice_of_competing_offer_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly requires the Company to notify Parent of the receipt of any Acquisition Proposal within twenty-four (24) hours.",
        "clause_text": "The Company shall (A) promptly (and in any case within twenty-four (24) hours) provide Parent notice (I) of the receipt of any Acquisition Proposal, which notice shall include a complete, unredacted copy of all written proposals, written indications of interest or draft agreements relating to, or other written materials that describe any of the material terms and conditions of, such Acquisition Proposal...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "notice_of_competing_offer_explanation",
        "answer": "The Company is required to notify the Parent of any Acquisition Proposal within twenty-four (24) hours, including providing a complete, unredacted copy of all written proposals and disclosing the identity of the other party and material terms.",
        "summary": "The Company must notify the Parent of any Acquisition Proposal within twenty-four (24) hours, including providing a complete, unredacted copy of all written proposals and disclosing the identity of the other party and material terms.",
        "confidence": 0.95,
        "reason": "The clause explicitly requires the Company to notify the Parent of any Acquisition Proposal and provide relevant details within a specified timeframe.",
        "clause_text": "The Company shall (A) promptly (and in any case within twenty-four (24) hours) provide Parent notice (I) of the receipt of any Acquisition Proposal, which notice shall include a complete, unredacted copy of all written proposals, written indications of interest or draft agreements relating to, or other written materials that describe any of the material terms and conditions of, such Acquisition Proposal, and (II) of any inquiries, proposals or offers received by, any requests for non-public information from, or any discussions or negotiations initiated or continued (or sought to be initiated or continued) with, the Company or any of its Representatives concerning an Acquisition Proposal, and disclose the identity of the other party (or parties) and the material terms of such inquiry, offer, proposal or request and, in the case of written materials that describe any of the material terms and conditions of such inquiry, offer, proposal or request, provide copies of such materials.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      }
    ],
    "ongoing_update": [
      {
        "section": "non_solicitation",
        "field_name": "ongoing_update_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement requires the Company to keep Parent informed on a reasonably prompt basis of the status and material details of any Acquisition Proposal.",
        "clause_text": "The Company shall (A) promptly (and in any case within twenty-four (24) hours) provide Parent notice (I) of the receipt of any Acquisition Proposal... and (C) keep Parent informed on a reasonably prompt basis (and, in any case, within twenty-four (24) hours of any significant development) of the status and material details (including amendments and proposed amendments) of any such Acquisition Proposal...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "ongoing_update_explanation",
        "answer": "The Company is obligated to provide ongoing updates to the Buyer about any changes in status or negotiations relating to a competing offer.",
        "summary": "The Company must promptly notify the Buyer within 24 hours of receiving any Acquisition Proposal, including providing copies of all relevant materials and keeping the Buyer informed of any significant developments.",
        "confidence": 0.9,
        "reason": "The clause specifies the Company's obligation to inform the Buyer within 24 hours of any Acquisition Proposal and to provide updates on significant developments.",
        "clause_text": "The Company shall (A) promptly (and in any case within twenty-four (24) hours) provide Parent notice (I) of the receipt of any Acquisition Proposal, which notice shall include a complete, unredacted copy of all written proposals, written indications of interest or draft agreements relating to, or other written materials that describe any of the material terms and conditions of, such Acquisition Proposal, and (II) of any inquiries, proposals or offers received by, any requests for non-public information from, or any discussions or negotiations initiated or continued (or sought to be initiated or continued) with, the Company or any of its Representatives concerning an Acquisition Proposal, and disclose the identity of the other party (or parties) and the material terms of such inquiry, offer, proposal or request and, in the case of written materials that describe any of the material terms and conditions of such inquiry, offer, proposal or request, provide copies of such materials, (B) promptly (and in any case within twenty-four (24) hours) make available to Parent all material non-public information, including copies of all written materials relating to the Company and its Subsidiaries, made available by the Company to such party but not previously made available to Parent and (C) keep Parent informed on a reasonably prompt basis (and, in any case, within twenty-four (24) hours of any significant development) of the status and material details (including amendments and proposed amendments) of any such Acquisition Proposal or other inquiry, offer, proposal or request and providing to Parent copies of any additional or revised written proposals or written indications of interest or draft agreements relating to such Acquisition Proposal or other inquiry, offer, proposal or request, or other written materials that describe any of the material terms and conditions of such Acquisition Proposal or other inquiry, offer, proposal or request.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      }
    ],
    "superior_proposal_engagement": [
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_engagement_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement allows the Company to engage in discussions or negotiations with a third party that submits a Superior Proposal, subject to certain conditions.",
        "clause_text": "Notwithstanding Section 5.6(a), at any time prior to obtaining the Company Stockholder Approval, if, after the date of this Agreement, the Company receives a bona fide written Acquisition Proposal from a third party that was not initiated, sought, solicited, knowingly facilitated, knowingly encouraged, knowingly induced or otherwise procured in violation, in any non-de minimis respect, of this Agreement, then the Company may... negotiate and participate in discussions and negotiations with such Person or any of its Representatives concerning such Acquisition Proposal.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_engagement_explanation",
        "answer": "The Company is authorized to engage with third parties if a Superior Proposal is received, provided the Company Board determines in good faith that the proposal constitutes or is reasonably likely to constitute a Superior Proposal.",
        "summary": "The Company may negotiate or share information with third parties if a Superior Proposal is received, contingent upon a good faith determination by the Company Board.",
        "confidence": 0.9,
        "reason": "The clause permits engagement with third parties if the Company Board determines in good faith that the proposal is a Superior Proposal.",
        "clause_text": "Notwithstanding Section 5.6(a), at any time prior to obtaining the Company Stockholder Approval, if, after the date of this Agreement, the Company receives a bona fide written Acquisition Proposal from a third party that was not initiated, sought, solicited, knowingly facilitated, knowingly encouraged, knowingly induced or otherwise procured in violation, in any non-de minimis respect, of this Agreement, then the Company may (i) contact the Person or any of its Representatives who has made such Acquisition Proposal solely to clarify the terms of such Acquisition Proposal so that the Company Board (or any committee thereof) may inform itself about such Acquisition Proposal, (ii) furnish information concerning its business, properties or assets to such Person or any of its Representatives pursuant to a confidentiality agreement with confidentiality terms that, taken as a whole, are not materially less favorable to the Company than those contained in the Confidentiality Agreement... and (iii) negotiate and participate in discussions and negotiations with such Person or any of its Representatives concerning such Acquisition Proposal, in the case of clauses (ii) and (iii), if the Company Board determines in good faith, after consultation with outside financial advisors and outside legal counsel, that such Acquisition Proposal constitutes or is reasonably likely to constitute or result in a Superior Proposal.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      }
    ],
    "match_right": [
      {
        "section": "non_solicitation",
        "field_name": "match_right_initial_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement grants the buyer a right to match an initial Superior Proposal by allowing the Company to negotiate with the Parent for four business days to modify the terms so that the proposal is no longer superior.",
        "clause_text": "for a period of four (4) Business Days following the notice delivered pursuant to clause (A) of this Section 5.6(d), the Company shall have discussed and negotiated in good faith (in each case only if Parent desires to negotiate) with Parent's Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement so that the Acquisition Proposal is no longer a Superior Proposal",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_initial_explanation",
        "answer": "The Company has provided Parent a copy of the proposed definitive agreements and other proposed transaction documentation between the Company and the Person making such Superior Proposal, if any, (C) for a period of four (4) Business Days following the notice delivered pursuant to clause (A) of this Section 5.6(d), the Company shall have discussed and negotiated in good faith (in each case only if Parent desires to negotiate) with Parent's Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement so that the Acquisition Proposal is no longer a Superior Proposal",
        "summary": "The Company must provide Parent with proposed agreements and negotiate in good faith for four business days to modify the terms so the Acquisition Proposal is no longer superior.",
        "confidence": 0.9,
        "reason": "The clause explicitly outlines the negotiation period and conditions for modifying the agreement.",
        "clause_text": "The Company has provided Parent a copy of the proposed definitive agreements and other proposed transaction documentation between the Company and the Person making such Superior Proposal, if any, (C) for a period of four (4) Business Days following the notice delivered pursuant to clause (A) of this Section 5.6(d), the Company shall have discussed and negotiated in good faith (in each case only if Parent desires to negotiate) with Parent's Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement so that the Acquisition Proposal is no longer a Superior Proposal",
        "reference_section": "ARTICLE Article V COVENANTS AND AGREEMENTS > Section 5.6 No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_amended_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly provides a renewed right to match for amended proposals.",
        "clause_text": "it being understood and agreed that any amendment to any material term or condition of any Superior Proposal shall require a new notice and a new negotiation period that shall expire on the later to occur of (I) two (2) Business Days following delivery of such new notice from the Company to Parent and (II) the expiration of the original four (4)-Business Day period described in this clause (C)",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_amended_explanation",
        "answer": "The agreement permits the Buyer to respond to a modified or revised Superior Proposal by providing a new notice and a new negotiation period that shall expire on the later to occur of two (2) Business Days following delivery of such new notice from the Company to Parent and the expiration of the original four (4)-Business Day period.",
        "summary": "The agreement allows the Buyer to respond to a modified Superior Proposal with a new notice and negotiation period, extending up to two additional Business Days.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions the requirement for a new notice and a new negotiation period in response to a modified Superior Proposal.",
        "clause_text": "it being understood and agreed that any amendment to any material term or condition of any Superior Proposal shall require a new notice and a new negotiation period that shall expire on the later to occur of (I) two (2) Business Days following delivery of such new notice from the Company to Parent and (II) the expiration of the original four (4)-Business Day period described in this clause (C)",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (d)"
      }
    ],
    "adverse_recommendation_change": [
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_superior_proposal_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The board of directors is permitted to change its recommendation in response to a Superior Proposal as outlined in Section 5.6(d).",
        "clause_text": "If, after the date of this Agreement and prior to the receipt of the Company Stockholder Approval, the Company Board receives a bona fide written Acquisition Proposal that the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, constitutes a Superior Proposal... the Company Board may (i) effect an Adverse Recommendation Change...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_superior_proposal_explanation",
        "answer": "The Company Board is permitted to change its recommendation in response to a Superior Proposal.",
        "summary": "The Company Board may effect an Adverse Recommendation Change if it receives a bona fide written Acquisition Proposal that constitutes a Superior Proposal, determined in good faith after consultation with outside financial advisors and legal counsel.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "If, after the date of this Agreement and prior to the receipt of the Company Stockholder Approval, the Company Board receives a bona fide written Acquisition Proposal that the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, constitutes a Superior Proposal...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_intervening_event_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly allows the Company Board to change its recommendation in response to an Intervening Event.",
        "clause_text": "Other than in connection with a Superior Proposal (which shall be subject to Section 5.6(d) and shall not be subject to this Section 5.6(e)), prior to obtaining the Company Stockholder Approval, the Company Board may, in response to an Intervening Event, take any action prohibited by clause (i) of Section 5.6(c), only if (i) the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, that the failure to take such action would be inconsistent with its fiduciary duties under applicable Law...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 No Solicitation by the Company > (e)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_intervening_event_explanation",
        "answer": "The Company Board may, in response to an Intervening Event, take any action prohibited by clause (i) of Section 5.6(c), only if (i) the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, that the failure to take such action would be inconsistent with its fiduciary duties under applicable Law, (ii) the Company has notified Parent in writing that the Company Board intends to effect such an Adverse Recommendation Change pursuant to this Section 5.6(e) (which notice shall specify the facts and circumstances providing the basis of the Intervening Event and for the Company Board's determination to effect such an Adverse Recommendation Change in reasonable detail), (iii) for a period of four (4) Business Days following the notice delivered pursuant to clause (ii) of this Section 5.6(e), the Company shall have discussed and negotiated in good faith (in each case only if Parent desires to negotiate) with Parent's Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement so that the failure to take such action would no longer be inconsistent with the Company Board's fiduciary duties under applicable Law (it being understood and agreed that any material change to the relevant facts and circumstances shall require a new notice and a new negotiation period that shall expire on the later to occur of (A) two (2) Business Days following delivery of such new notice from the Company to Parent and (B) the expiration of the original four (4) Business Day period described above in this clause (iii)), and (iv) no earlier than the end of such negotiation period, the Company Board shall have determined in good faith, after consultation with its outside financial advisors and outside legal counsel, and after considering the terms of any proposed amendment or modification to this Agreement, that the failure to take such action would still be inconsistent with its fiduciary duties under applicable Law.",
        "summary": "The Company Board may change its recommendation due to an Intervening Event if it determines in good faith that not doing so would be inconsistent with its fiduciary duties, after notifying Parent and negotiating in good faith.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "The Company Board may, in response to an Intervening Event, take any action prohibited by clause (i) of Section 5.6(c), only if (i) the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, that the failure to take such action would be inconsistent with its fiduciary duties under applicable Law, (ii) the Company has notified Parent in writing that the Company Board intends to effect such an Adverse Recommendation Change pursuant to this Section 5.6(e) (which notice shall specify the facts and circumstances providing the basis of the Intervening Event and for the Company Board's determination to effect such an Adverse Recommendation Change in reasonable detail), (iii) for a period of four (4) Business Days following the notice delivered pursuant to clause (ii) of this Section 5.6(e), the Company shall have discussed and negotiated in good faith (in each case only if Parent desires to negotiate) with Parent's Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement so that the failure to take such action would no longer be inconsistent with the Company Board's fiduciary duties under applicable Law (it being understood and agreed that any material change to the relevant facts and circumstances shall require a new notice and a new negotiation period that shall expire on the later to occur of (A) two (2) Business Days following delivery of such new notice from the Company to Parent and (B) the expiration of the original four (4) Business Day period described above in this clause (iii)), and (iv) no earlier than the end of such negotiation period, the Company Board shall have determined in good faith, after consultation with its outside financial advisors and outside legal counsel, and after considering the terms of any proposed amendment or modification to this Agreement, that the failure to take such action would still be inconsistent with its fiduciary duties under applicable Law.",
        "reference_section": "ARTICLE Article V COVENANTS AND AGREEMENTS > Section 5.6 No Solicitation by the Company > (e)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_timing",
        "answer": "The Company Board must provide Parent with a written notice of its intent to make an Adverse Recommendation Change and engage in good faith negotiations for four (4) Business Days before making such a change.",
        "summary": "The Company Board must provide Parent with a written notice of its intent to make an Adverse Recommendation Change and engage in good faith negotiations for four (4) Business Days before making such a change.",
        "confidence": 0.9,
        "reason": "The document specifies a four (4) Business Day negotiation period following notice to Parent before an Adverse Recommendation Change can be made.",
        "clause_text": "If, after the date of this Agreement and prior to the receipt of the Company Stockholder Approval, the Company Board receives a bona fide written Acquisition Proposal that the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, constitutes a Superior Proposal that was not initiated, sought, solicited, knowingly facilitated, knowingly encouraged, knowingly induced or otherwise procured in violation, in any non-de minimis respect, of this Agreement, the Company Board may (i) effect an Adverse Recommendation Change or (ii) cause the Company to terminate this Agreement pursuant to Section 7.1(c)(ii) in order to enter into a definitive agreement providing for such Superior Proposal if, in each case, (A) the Company has notified Parent in writing that the Company Board intends to effect an Adverse Recommendation Change pursuant to this Section 5.6(d) or terminate this Agreement pursuant to Section 7.1(c)(ii), (B) the Company has provided Parent a copy of the proposed definitive agreements and other proposed transaction documentation between the Company and the Person making such Superior Proposal, if any, (C) for a period of four (4) Business Days following the notice delivered pursuant to clause (A) of this Section 5.6(d), the Company shall have discussed and negotiated in good faith (in each case only if Parent desires to negotiate) with Parent's Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement so that the Acquisition Proposal is no longer a Superior Proposal (it being understood and agreed that any amendment to any material term or condition of any Superior Proposal shall require a new notice and a new negotiation period that shall expire on the later to occur of (I) two (2) Business Days following delivery of such new notice from the Company to Parent and (II) the expiration of the original four (4)-Business Day period described in this clause (C)), and (D) no earlier than the end of such negotiation period, the Company Board shall have determined in good faith, after consultation with its outside financial advisors and outside legal counsel, and after considering the terms of any proposed amendment or modification to this Agreement, that the Acquisition Proposal that is the subject of the notice described in clause (B) above still constitutes a Superior Proposal; provided that any purported termination of this Agreement pursuant to this sentence shall be void and of no force and effect unless the Company shall have paid Merger Sub (or a United States Affiliate of Merger Sub as Merger Sub may designate) the Termination Amount in accordance with Section 7.3(a) prior to or substantially concurrently with such termination.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (d)"
      }
    ],
    "go_shop": [
      {
        "section": "non_solicitation",
        "field_name": "go_shop_included",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement prohibits solicitation and does not mention a 'go-shop' period or any provision allowing the Company to actively solicit competing acquisition proposals after signing.",
        "clause_text": "From the date of this Agreement until the earlier of the Effective Time and the termination of this Agreement in accordance with Section 7.1, except as provided in Section 5.6(b) or Section 5.6(d), (i) the Company shall, and shall cause its Subsidiaries, and its and their respective officers and directors to, immediately cease, and shall instruct and use its reasonable best efforts to cause its and their respective other Representatives to immediately cease, and cause to be terminated all existing discussions, negotiations and communications with any Persons or entities with respect to any Acquisition Proposal (other than the transactions contemplated by this Agreement).",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (a)"
      },
      {
        "section": "non_solicitation",
        "field_name": "go_shop_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "buyer_diligence_access": [
      {
        "section": "non_solicitation",
        "field_name": "buyer_diligence_access_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement grants the buyer the right to receive any diligence materials shared with a third party, as indicated by the requirement to provide Parent with all material non-public information made available to a third party.",
        "clause_text": "The Company shall (A) promptly (and in any case within twenty-four (24) hours) provide Parent notice (I) of the receipt of any Acquisition Proposal, which notice shall include a complete, unredacted copy of all written proposals, written indications of interest or draft agreements relating to, or other written materials that describe any of the material terms and conditions of, such Acquisition Proposal, and (II) of any inquiries, proposals or offers received by, any requests for non-public information from, or any discussions or negotiations initiated or continued (or sought to be initiated or continued) with, the Company or any of its Representatives concerning an Acquisition Proposal, and disclose the identity of the other party (or parties) and the material terms of such inquiry, offer, proposal or request and, in the case of written materials that describe any of the material terms and conditions of such inquiry, offer, proposal or request, provide copies of such materials, (B) promptly (and in any case within twenty-four (24) hours) make available to Parent all material non-public information, including copies of all written materials relating to the Company and its Subsidiaries, made available by the Company to such party but not previously made available to Parent",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "buyer_diligence_access_explanation",
        "answer": "Parent shall be provided",
        "summary": "The Company is obligated to promptly provide Parent with all material non-public information made available to a third party in connection with an Acquisition Proposal.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "The Company shall (A) promptly (and in any case within twenty-four (24) hours) provide Parent notice (I) of the receipt of any Acquisition Proposal, which notice shall include a complete, unredacted copy of all written proposals, written indications of interest or draft agreements relating to, or other written materials that describe any of the material terms and conditions of, such Acquisition Proposal, and (II) of any inquiries, proposals or offers received by, any requests for non-public information from, or any discussions or negotiations initiated or continued (or sought to be initiated or continued) with, the Company or any of its Representatives concerning an Acquisition Proposal, and disclose the identity of the other party (or parties) and the material terms of such inquiry, offer, proposal or request and, in the case of written materials that describe any of the material terms and conditions of such inquiry, offer, proposal or request, provide copies of such materials, (B) promptly (and in any case within twenty-four (24) hours) make available to Parent all material non-public information, including copies of all written materials relating to the Company and its Subsidiaries, made available by the Company to such party but not previously made available to Parent and (C) keep Parent informed on a reasonably prompt basis (and, in any case, within twenty-four (24) hours of any significant development) of the status and material details (including amendments and proposed amendments) of any such Acquisition Proposal or other inquiry, offer, proposal or request and providing to Parent copies of any additional or revised written proposals or written indications of interest or draft agreements relating to such Acquisition Proposal or other inquiry, offer, proposal or request, or other written materials that describe any of the material terms and conditions of such Acquisition Proposal or other inquiry, offer, proposal or request.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      }
    ],
    "recommendation_change_restriction": [
      {
        "section": "non_solicitation",
        "field_name": "recommendation_change_restriction_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement imposes restrictions on the board's ability to change its recommendation, requiring prior notice to the Parent and a negotiation period.",
        "clause_text": "If, after the date of this Agreement and prior to the receipt of the Company Stockholder Approval, the Company Board receives a bona fide written Acquisition Proposal that the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, constitutes a Superior Proposal... (A) the Company has notified Parent in writing that the Company Board intends to effect an Adverse Recommendation Change...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "recommendation_change_restriction_explanation",
        "answer": "The agreement imposes procedural and timing-based restrictions on how the Company may change its recommendation.",
        "summary": "The Company must notify Parent in writing of its intent to change its recommendation, provide a copy of proposed agreements, engage in good faith negotiations for four business days, and determine in good faith that the proposal remains superior.",
        "confidence": 0.9,
        "reason": "The agreement outlines specific steps and waiting periods before a recommendation change can be communicated.",
        "clause_text": "If, after the date of this Agreement and prior to the receipt of the Company Stockholder Approval, the Company Board receives a bona fide written Acquisition Proposal that the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, constitutes a Superior Proposal... (A) the Company has notified Parent in writing that the Company Board intends to effect an Adverse Recommendation Change... (C) for a period of four (4) Business Days following the notice delivered... the Company shall have discussed and negotiated in good faith...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (d)"
      }
    ]
  },
  "best_efforts": {
    "regulatory_efforts": [
      {
        "section": "best_efforts",
        "field_name": "effort_standard",
        "answer": "Reasonable Best Efforts",
        "summary": "The parties are required to use their reasonable best efforts to obtain regulatory approvals and satisfy conditions for the merger as promptly as reasonably practicable.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the parties will use their 'reasonable best efforts' to consummate the transactions and obtain necessary approvals.",
        "clause_text": "Subject to the terms and conditions of this Agreement, the parties hereto will cooperate with each other and use (and will cause their respective Subsidiaries to use) their respective reasonable best efforts to consummate the transactions contemplated by this Agreement and to cause the conditions to the Merger set forth in Article VI to be satisfied as promptly as reasonably practicable...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "effort_scope",
        "answer": "RBE for HSR and other applicable Antitrust Laws",
        "summary": "The effort standard applies to filings under the HSR Act and other applicable Antitrust Laws as determined by the Company and Parent.",
        "confidence": 0.9,
        "reason": "The clause specifies the requirement for filings under the HSR Act and other applicable Antitrust Laws.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act, and make any other applications and filings as reasonably determined by the Company and Parent under other applicable Antitrust Laws with respect to the transactions contemplated by this Agreement, as promptly as practicable, but in no event later than as required by Law.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "regulatory_fillings_hsr": [
      {
        "section": "best_efforts",
        "field_name": "hsr_required",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document explicitly states that the expiration or early termination of the HSR waiting period is a condition to closing.",
        "clause_text": "The respective obligations of each party to consummate the Merger are subject to the satisfaction or (to the extent permitted by Law) waiver by the Company and Parent at or prior to the Closing of the following conditions: ... (d) any applicable waiting period (and any extension thereof) under the HSR Act relating to the consummation of the Merger shall have expired or early termination thereof shall have been granted (the 'Required Regulatory Approval');",
        "reference_section": "ARTICLE VI – Conditions to the Merger > Section 6.1 – Conditions to the Obligations of Each Party"
      },
      {
        "section": "best_efforts",
        "field_name": "hsr_filing_deadline_days",
        "answer": 25,
        "summary": "The parties are required to make their respective filings under the HSR Act no later than twenty-five (25) Business Days following the date of the Agreement.",
        "confidence": 1.0,
        "reason": "The document explicitly states the deadline for HSR filings as twenty-five (25) Business Days following the date of the Agreement.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "hsr_notes",
        "answer": "Must file within 25 business days of signing; filing required under HSR Act as a condition to closing.",
        "summary": "The parties must make their respective filings under the HSR Act within 25 business days following the date of the Agreement, and the expiration or early termination of the HSR waiting period is a condition to closing.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act, and make any other applications and filings as reasonably determined by the Company and Parent under other applicable Antitrust Laws with respect to the transactions contemplated by this Agreement, as promptly as practicable, but in no event later than as required by Law.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "regulatory_fillings_cfius": [
      {
        "section": "best_efforts",
        "field_name": "cfius_required",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no mention of a CFIUS filing or clearance requirement in the provided sections.",
        "clause_text": "The provided sections do not contain any reference to CFIUS or related foreign investment review requirements.",
        "reference_section": "Not applicable as there is no relevant section mentioning CFIUS."
      },
      {
        "section": "best_efforts",
        "field_name": "cfius_filing_deadline_days",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "cfius_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_fillings_foreign": [
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_notes",
        "answer": "Foreign filings may be required under applicable non-U.S. laws",
        "summary": "The agreement requires the parties to make filings under other applicable Antitrust Laws, which implies that foreign filings may be necessary.",
        "confidence": 0.9,
        "reason": "The language in Section 5.4(a) suggests that filings under other applicable Antitrust Laws, which could include foreign laws, are required.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act, and make any other applications and filings as reasonably determined by the Company and Parent under other applicable Antitrust Laws with respect to the transactions contemplated by this Agreement, as promptly as practicable, but in no event later than as required by Law.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_required",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement requires filings under 'other applicable Antitrust Laws,' which implies foreign filings are required.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act, and make any other applications and filings as reasonably determined by the Company and Parent under other applicable Antitrust Laws with respect to the transactions contemplated by this Agreement, as promptly as practicable, but in no event later than as required by Law.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_deadline_days",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "divestiture_commitments": [
      {
        "section": "best_efforts",
        "field_name": "divestiture_required",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly permits Remedy Actions, including divestiture, to secure regulatory approval.",
        "clause_text": "Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law... including agreeing to, committing to, proffering, proposing or taking any action required to sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_value",
        "answer": 140,
        "summary": "The divestiture cap is set at $140,000,000 in net sales for the Company's businesses and products during the 2024 fiscal year.",
        "confidence": 0.9,
        "reason": "The agreement specifies a divestiture limitation based on net sales exceeding $140,000,000.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_unit",
        "answer": "USD_millions",
        "summary": "The agreement limits divestiture actions to businesses and products of the Company and its Subsidiaries that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "confidence": 0.9,
        "reason": "The clause specifies a divestiture cap based on net sales exceeding $140,000,000.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_basis",
        "answer": "revenue",
        "summary": "The divestiture cap for the Target is measured against 'net sales', which is normalized to 'revenue'.",
        "confidence": 0.9,
        "reason": "The clause specifies a divestiture cap based on 'net sales', which is equivalent to 'revenue'.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_basis_scope",
        "answer": "Target",
        "summary": "The divestiture cap is applied to the businesses and products of the Company and its Subsidiaries, as indicated by the reference to net sales generated by them.",
        "confidence": 0.9,
        "reason": "The clause specifies divestiture actions related to the Company's businesses and products, indicating the scope is based on the Target.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_notes",
        "answer": "Cap applies to Target units generating more than $140,000,000 in net sales during the Company's 2024 fiscal year.",
        "summary": "The divestiture cap applies to the Company's businesses and products that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "confidence": 0.9,
        "reason": "The clause specifies a divestiture cap based on net sales exceeding $140,000,000 during the 2024 fiscal year.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_value",
        "answer": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)",
        "summary": "The divestiture cap for buyer value is implied in the clause where Parent and its Subsidiaries are not required to take Remedy Actions with respect to businesses and products of the Company that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "confidence": 0.9,
        "reason": "The clause specifies a financial threshold for divestiture actions, implying a cap on buyer value.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_unit",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_basis",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_basis_scope",
        "answer": "Parent",
        "summary": "The divestiture cap applies to the operations or assets of Parent and its Subsidiaries, as indicated by the reference to Parent and its Subsidiaries in the context of divestiture commitments.",
        "confidence": 0.9,
        "reason": "The clause specifies that Parent and its Subsidiaries are involved in divestiture actions, implying their operations or assets are within the divestiture cap.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year or (II) of Parent and its Subsidiaries (other than, following the Closing, and subject to the preceding clause (I), the Company and its Subsidiaries).",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_notes",
        "answer": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "summary": "The Buyer (Parent) is not required to take Remedy Actions involving divestitures of businesses and products of the Company that generated net sales exceeding $140,000,000 in the 2024 fiscal year.",
        "confidence": 0.9,
        "reason": "The clause explicitly limits the Parent's obligation to take Remedy Actions based on the sales threshold of the Company's businesses.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_scope_exclusions",
        "answer": "Parent and its Subsidiaries' businesses and products",
        "summary": "Parent and its Subsidiaries' businesses and products are excluded from divestiture or Remedy Actions unless they are conditioned upon the consummation of the transactions.",
        "confidence": 0.9,
        "reason": "The clause specifies that Parent and its Subsidiaries' businesses and products are excluded from Remedy Actions unless conditioned upon the consummation of the transactions.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year or (II) of Parent and its Subsidiaries (other than, following the Closing, and subject to the preceding clause (I), the Company and its Subsidiaries);",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_clause_summary",
        "answer": "Parent, Merger Sub, and Parent's Subsidiaries are obligated to take necessary actions, including divestitures, to obtain regulatory approval, but are not required to divest businesses generating net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "summary": "Parent and its subsidiaries must take necessary actions, including divestitures, to obtain regulatory approval, with a threshold that excludes divestitures of businesses generating over $140 million in net sales.",
        "confidence": 0.9,
        "reason": "The clause specifies obligations for divestitures with a clear threshold, indicating a divestiture commitment with conditions.",
        "clause_text": "Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law... including agreeing to, committing to, proffering, proposing or taking any action required to sell, divest... provided, however, that... Parent and its Subsidiaries shall not be required to agree to... any businesses and products... that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      }
    ],
    "litigation_commitments": [
      {
        "section": "best_efforts",
        "field_name": "litigation_requirement_status",
        "answer": "Explicit Requirement to Litigate",
        "summary": "The agreement requires the parties to defend through litigation any proceedings that challenge the merger, including seeking to vacate or reverse any court orders that would delay the transaction.",
        "confidence": 0.9,
        "reason": "The language in Section 5.4(d) explicitly requires defending through litigation any proceedings that challenge the merger.",
        "clause_text": "Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law and to obtain the consent or cooperation of any other Person, and to permit and cause the satisfaction of the conditions set forth in Article VI, in each case, to permit the Closing to occur as promptly as reasonably practicable and in any event prior to the Termination Date, including (i) defending through litigation on the merits or otherwise, including appeals, any Proceeding asserted by any Person or Governmental Authority with respect to this Agreement or the Merger or the other transactions contemplated by this Agreement that seeks or would reasonably be expected to prevent, prohibit, interfere with or delay the Closing...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "litigation_clause_scope",
        "answer": "Litigate through appeals unless businesses generating over $140,000,000 in net sales are affected",
        "summary": "The Buyer is obligated to defend through litigation on the merits, including appeals, unless it involves businesses generating over $140,000,000 in net sales.",
        "confidence": 0.9,
        "reason": "The clause specifies that litigation, including appeals, is required unless it involves significant business sales.",
        "clause_text": "Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law and to obtain the consent or cooperation of any other Person, and to permit and cause the satisfaction of the conditions set forth in Article VI, in each case, to permit the Closing to occur as promptly as reasonably practicable and in any event prior to the Termination Date, including (i) defending through litigation on the merits or otherwise, including appeals, any Proceeding asserted by any Person or Governmental Authority with respect to this Agreement or the Merger or the other transactions contemplated by this Agreement that seeks or would reasonably be expected to prevent, prohibit, interfere with or delay the Closing and (ii) agreeing to, committing to, proffering, proposing or taking any action required to sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines (including, for the avoidance of doubt, any equity or other interests in the Company), or its or their ability to own or operate any of the foregoing, or any other restriction, limitation or condition on or with respect to the foregoing or with respect to the Company's or any of their respective Affiliate's freedom to operate (any of the foregoing in this clause (ii), a \"Remedy Action\"); provided, however, that with respect to this clause (ii), (A) Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year or (II) of Parent and its Subsidiaries (other than, following the Closing, and subject to the preceding clause (I), the Company and its Subsidiaries);",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "required_to_litigate_notes",
        "answer": "Parent must litigate regulatory challenges through appeals unless conditions to closing are impossible.",
        "summary": "Parent must litigate regulatory challenges through appeals unless conditions to closing are impossible.",
        "confidence": 0.9,
        "reason": "The clause specifies that Parent must defend through litigation on the merits, including appeals, any Proceeding that seeks to prevent, prohibit, interfere with or delay the Closing.",
        "clause_text": "Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law and to obtain the consent or cooperation of any other Person, and to permit and cause the satisfaction of the conditions set forth in Article VI, in each case, to permit the Closing to occur as promptly as reasonably practicable and in any event prior to the Termination Date, including (i) defending through litigation on the merits or otherwise, including appeals, any Proceeding asserted by any Person or Governmental Authority with respect to this Agreement or the Merger or the other transactions contemplated by this Agreement that seeks or would reasonably be expected to prevent, prohibit, interfere with or delay the Closing",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      }
    ],
    "withdrawal_and_timing_controls_withdrawal": [
      {
        "section": "best_efforts",
        "field_name": "withdrawal_control_type",
        "answer": "mutual_consent_required",
        "summary": "The agreement specifies that neither the Company nor Parent will withdraw any filings or applications without the prior written consent of the other party.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that withdrawal of filings requires mutual consent.",
        "clause_text": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "withdrawal_control_type_notes",
        "answer": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "summary": "The withdrawal of regulatory filings requires prior written consent from the other party, which cannot be unreasonably withheld, conditioned, or delayed.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the conditions under which regulatory filings may be withdrawn, including the requirement for mutual consent.",
        "clause_text": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "withdrawal_and_timing_controls_timing": [
      {
        "section": "best_efforts",
        "field_name": "timing_agreement_restriction",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that neither party shall enter into any timing or similar agreement under the HSR Act without the other party’s prior written consent.",
        "clause_text": "None of Parent, Merger Sub or the Company (including their respective Subsidiaries) shall, without the other party's prior written consent, enter into any timing or similar agreement, or otherwise agree or commit to any arrangement, that would have the effect of extending, suspending, lengthening or otherwise tolling the expiration or termination of any waiting period applicable to consummate the transactions contemplated by this Agreement under the HSR Act, such consent not to be unreasonably withheld, conditioned or delayed.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "timing_agreement_restriction_notes",
        "answer": "The agreement restricts the withdrawal or modification of filings under the HSR Act without prior written consent, which cannot be unreasonably withheld.",
        "summary": "The agreement restricts the withdrawal or modification of filings under the HSR Act without prior written consent, which cannot be unreasonably withheld.",
        "confidence": 0.9,
        "reason": "The clause specifies that neither party will withdraw filings under the HSR Act without the other's prior written consent, which cannot be unreasonably withheld.",
        "clause_text": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "remedy_actions_other": [
      {
        "section": "best_efforts",
        "field_name": "remedy_definitions_provided",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The term 'Remedy Action' is defined in the agreement as actions required to address antitrust concerns, including selling or divesting assets.",
        "clause_text": "any other restriction, limitation or condition on or with respect to the foregoing or with respect to the Company's or any of their respective Affiliate's freedom to operate (any of the foregoing in this clause (ii), a 'Remedy Action');",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "remedy_definition_text",
        "answer": "sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines",
        "summary": "A 'Remedy Action' involves actions such as selling, divesting, holding separate, leasing, licensing, transferring, disposing of, or otherwise encumbering or impairing the Company's or its Affiliates' assets, properties, businesses, or product lines.",
        "confidence": 0.9,
        "reason": "The term 'Remedy Action' is explicitly defined in the context of antitrust law compliance.",
        "clause_text": "agreeing to, committing to, proffering, proposing or taking any action required to sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      }
    ],
    "transaction_interference": [
      {
        "section": "best_efforts",
        "field_name": "restriction_on_other_transactions",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement restricts the Company from soliciting or pursuing alternative transactions that could interfere with regulatory approvals.",
        "clause_text": "the Company shall not, and shall not authorize, and shall use its reasonable best efforts not to permit, any of its Representatives to, directly or indirectly through another Person, (A) initiate, seek, solicit, knowingly facilitate, knowingly encourage (including by way of furnishing any non-public information) or knowingly induce or knowingly take any other action which would reasonably be expected to lead to an Acquisition Proposal",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "interference_clause_text",
        "answer": "sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines",
        "summary": "A 'Remedy Action' includes actions such as selling, divesting, or otherwise altering the Company's assets or business lines to comply with antitrust laws.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "agreeing to, committing to, proffering, proposing or taking any action required to sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines (including, for the avoidance of doubt, any equity or other interests in the Company), or its or their ability to own or operate any of the foregoing, or any other restriction, limitation or condition on or with respect to the foregoing or with respect to the Company's or any of their respective Affiliate's freedom to operate (any of the foregoing in this clause (ii), a 'Remedy Action')",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      }
    ],
    "second_request_certification": [
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_deadline_specified",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no explicit language specifying a concrete deadline for certifying compliance with the Second Request under the HSR Act.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_certification_timeline_notes",
        "answer": "as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement",
        "summary": "The parties are required to make their respective filings under the HSR Act as promptly as reasonably practicable, but no later than twenty-five (25) Business Days following the date of the Agreement.",
        "confidence": 0.9,
        "reason": "The clause specifies a timeline for HSR Act filings, indicating a clear deadline.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_responsibility_party",
        "answer": "Both",
        "summary": "Both parties are required to cooperate and use their reasonable best efforts to make filings under the HSR Act, indicating shared responsibility for certifying compliance.",
        "confidence": 0.9,
        "reason": "The agreement specifies that each party must make its respective filings under the HSR Act, implying joint responsibility.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "ftc_warning_letter_handling": [
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_addressed",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not mention FTC warning letters or any synonymous phrases related to preliminary regulatory communications.",
        "clause_text": "The document sections provided focus on compliance with Customs & International Trade Laws, Sanctions, and other regulatory matters but do not address FTC warning letters or similar communications.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings"
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_notes",
        "answer": "Not addressed",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_effect_on_closing_condition",
        "answer": "Silent",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_addressed_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "other_timing_controls": [
      {
        "section": "best_efforts",
        "field_name": "other_timing_controls_deadlines_specified",
        "answer": [
          "Company Stockholders' Meeting to occur within 50 days of F-4 effectiveness",
          "Adjournments or postponements of the Company Stockholders' Meeting shall be for a period of no more than 25 Business Days in the aggregate"
        ],
        "summary": "The agreement specifies that the Company Stockholders' Meeting must occur within 50 days of the Form F-4 effectiveness, and any adjournments or postponements of this meeting are limited to a total of 25 Business Days.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Subject to the earlier termination of this Agreement in accordance with Section 7.1, the Company shall, as soon as reasonably practicable following the effectiveness of the Form F-4, duly call, give notice of, convene (on a date selected by the Company in consultation with Parent, which date shall be within, subject to adjournment or postponement as provided below, fifty (50) days of the effectiveness of the Form F-4) and hold a meeting of its stockholders (the \"Company Stockholders' Meeting\") for the purpose of seeking the Company Stockholder Approval... provided, however, that unless agreed to in writing by Parent, any such adjournments or postponements under this clause (ii) shall be for a period of no more than twenty-five (25) Business Days in the aggregate;",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      }
    ],
    "novel_or_unstructured_regulatory_clauses": [
      {
        "section": "best_efforts",
        "field_name": "novel_or_unstructured_regulatory_clauses_items",
        "answer": [
          {
            "summary": "Neither the Company nor Parent will withdraw any filings or applications without the prior written consent of the other party, and such consent cannot be unreasonably withheld, conditioned, or delayed.",
            "section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)",
            "review_required": true
          },
          {
            "summary": "No party shall enter into any timing or similar agreement that would extend or toll the expiration or termination of any waiting period under the HSR Act without the other party's prior written consent, which cannot be unreasonably withheld, conditioned, or delayed.",
            "section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)",
            "review_required": true
          },
          {
            "summary": "Parent and its Subsidiaries are not required to take any Remedy Actions with respect to businesses and products of the Company that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
            "section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)",
            "review_required": true
          },
          {
            "summary": "The Company shall not agree to any Remedy Actions without Parent's prior written consent.",
            "section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)",
            "review_required": true
          }
        ],
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "prior_approval_commitment": [
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_addressed",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not explicitly mention an obligation to obtain prior approval from a third party for future actions beyond the merger itself.",
        "clause_text": "The respective obligations of each party to consummate the Merger are subject to the satisfaction or (to the extent permitted by Law) waiver by the Company and Parent at or prior to the Closing of the following conditions: (a) the Company shall have obtained the Company Stockholder Approval; (b) the Parent Share Issuance shall have been approved for listing on the NYSE, subject to official notice of issuance; (c) the Form F-4 shall have become effective under the Securities Act and shall not be the subject of any stop order or any Proceedings by or before the SEC seeking a stop order; (d) any applicable waiting period (and any extension thereof) under the HSR Act relating to the consummation of the Merger shall have expired or early termination thereof shall have been granted (the \"Required Regulatory Approval\"); and (e) no Governmental Authority of competent jurisdiction shall have issued or entered any Order after the date of this Agreement, and no Law shall have been enacted or promulgated after the date of this Agreement, in each case, that (whether temporary or permanent) is then in effect and has the effect of enjoining or otherwise prohibiting the consummation of the Merger (a \"Restraint\").",
        "reference_section": "ARTICLE VI – Conditions to the Merger > Section 6.1 – Conditions to the Obligations of Each Party"
      },
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_obligations_summary",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_process_control_discretion": [
      {
        "section": "best_efforts",
        "field_name": "regulatory_process_control_discretion",
        "answer": "Joint, mutual consent required",
        "summary": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "confidence": 0.9,
        "reason": "The agreement explicitly requires both parties' consent for withdrawing filings or applications.",
        "clause_text": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "parent_has_sole_discretion_excluding_remedies",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement specifies that regulatory filings and related actions require cooperation and mutual consent, not sole discretion by the Parent.",
        "clause_text": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "no_limitations_on_buyer_remedies": [
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_value",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly limits the Buyer's obligation to take Remedy Actions by stating that Parent and its Subsidiaries are not required to take Remedy Actions with respect to businesses and products that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_inferred_hohw",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The presence of material carveouts in Section 5.4(d) indicates that the Buyer is not under a Hell-or-High-Water obligation.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year or (II) of Parent and its Subsidiaries.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_explanation",
        "answer": "Not applicable",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_notes",
        "answer": "Not Found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_inferred_hohw_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_materiality_basis",
        "answer": "relative to Buyer",
        "summary": "The agreement specifies that Parent and its Subsidiaries are not required to take Remedy Actions with respect to businesses and products of the Company and its Subsidiaries that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "confidence": 0.9,
        "reason": "The clause specifies a threshold for Remedy Actions based on the financial impact relative to the Buyer.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "materiality_definition_text",
        "answer": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "summary": "The Buyer is not required to take Remedy Actions affecting businesses with net sales exceeding $140 million during the Company's 2024 fiscal year.",
        "confidence": 0.95,
        "reason": "The clause explicitly states a financial threshold for Remedy Actions, limiting the Buyer's obligations.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      }
    ],
    "refiling_commitment": [
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_required",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document specifies that neither the Company nor Parent will withdraw any HSR Act filings or applications without the prior written consent of the other party.",
        "clause_text": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_required_notes",
        "answer": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "summary": "The agreement requires that neither the Company nor Parent can withdraw filings under the HSR Act without the prior written consent of the other party, ensuring mutual cooperation in regulatory processes.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the requirement for mutual consent before withdrawing HSR Act filings, indicating a commitment to refile if necessary.",
        "clause_text": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles_notes",
        "answer": "Not Specified",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles_specification_status",
        "answer": "Not Specified",
        "summary": "The agreement does not specify a limit on the number of HSR refilings, nor does it state that refilings are unlimited.",
        "confidence": 0.8,
        "reason": "The agreement mentions the requirement for HSR filings but does not specify a limit or explicitly state that refilings are unlimited.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ]
  },
  "termination": {
    "outside_date": [
      {
        "section": "termination",
        "field_name": "primary_date",
        "answer": "5:00 p.m. (Chicago, Illinois, United States time) on the twelve (12)-month anniversary of the date of this Agreement",
        "summary": "The initial Outside Date is specified as the twelve-month anniversary of the date of the Agreement, at which point either party may terminate if the merger has not closed.",
        "confidence": 0.95,
        "reason": "The agreement explicitly states the Outside Date as the twelve-month anniversary of the agreement date.",
        "clause_text": "the Merger shall not have been consummated on or before 5:00 p.m. (Chicago, Illinois, United States time) on the twelve (12)-month anniversary of the date of this Agreement (the \"Termination Date\");",
        "reference_section": "ARTICLE Article VII TERMINATION, AMENDMENT AND WAIVER > Section 7.1 Termination > (b) > (i)"
      }
    ],
    "extension": [
      {
        "section": "termination",
        "field_name": "extension_list",
        "answer": [
          {
            "Extension Length": "3 months",
            "Who Grants the Extension": "automatic",
            "Conditions to Extend": "if any of the conditions to Closing set forth in Section 6.1(d) or Section 6.1(e) (if the Restraint is in respect of an Antitrust Law) shall not have been satisfied, but all other conditions set forth in Section 6.1 through Section 6.3 shall have been satisfied or waived",
            "Termination Restrictions Due to Breach": "Yes, the right to terminate is not available to any party if a material breach by such party has been the principal cause of or principally resulted in the failure of the Closing to have occurred on or before the Termination Date."
          }
        ],
        "summary": "The Termination Date is automatically extended by 3 months if certain conditions related to regulatory approval are unmet, provided all other conditions are satisfied. Termination rights are restricted if a party's material breach caused the failure to close.",
        "confidence": 0.95,
        "reason": "The agreement specifies automatic extension and conditions for extension, and restricts termination rights in case of a party's material breach.",
        "clause_text": "provided that if, on the Termination Date, any of the conditions to Closing set forth in Section 6.1(d) or Section 6.1(e) (if the Restraint is in respect of an Antitrust Law) shall not have been satisfied, but all other conditions set forth in Section 6.1 through Section 6.3 shall have been satisfied or waived...the Termination Date shall automatically, without any action on the part of the parties hereto, be extended for three (3) months...",
        "reference_section": "ARTICLE VII – Termination, Amendment and Waiver > Section 7.1 Termination > (b)(i)"
      }
    ],
    "termination_fee": [
      {
        "section": "termination",
        "field_name": "termination_fee",
        "answer": "$272,000,000",
        "summary": "The Termination Amount payable by the Target to the Parent is explicitly defined as $272,000,000.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Termination Amount shall mean $272,000,000.",
        "reference_section": "Definition > Termination Amount"
      }
    ],
    "reverse_termination_fee": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee",
        "answer": 272000000,
        "summary": "The Termination Amount, which functions as a reverse termination fee, is explicitly defined as $272,000,000.",
        "confidence": 0.95,
        "reason": "The Termination Amount is clearly defined in the agreement as $272,000,000, which is payable under certain termination conditions.",
        "clause_text": "Termination Amount shall mean $272,000,000.",
        "reference_section": "Definition > Termination Amount"
      }
    ],
    "reverse_termination_fee_exist": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee_exist",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement specifies a termination fee payable by the Company to the Merger Sub, but there is no provision for a reverse termination fee from the Parent to the Company.",
        "clause_text": "then, in any such case, the Company shall pay, or cause to be paid, to Merger Sub (or a United States Affiliate of Merger Sub as Merger Sub may designate) the Termination Amount.",
        "reference_section": "ARTICLE VII – Termination, Amendment and Waiver > Section 7.3 Termination Amount > (a)"
      }
    ]
  },
  "ordinary_course": {
    "ordinary_course_covenant": [
      {
        "section": "ordinary_course",
        "field_name": "concise_standard_summary",
        "answer": "The Company and Parent are required to use commercially reasonable efforts to conduct their businesses in the ordinary course and preserve their assets and business relationships between signing and closing.",
        "summary": "The Company and Parent must use commercially reasonable efforts to conduct their businesses in the ordinary course and preserve their assets and business relationships between signing and closing.",
        "confidence": 0.95,
        "reason": "The document specifies that both the Company and Parent must use commercially reasonable efforts to maintain ordinary business operations and relationships.",
        "clause_text": "The Company shall, and shall cause its Subsidiaries to, use commercially reasonable efforts to conduct the business of the Company and its Subsidiaries in the ordinary course of business and, to the extent consistent therewith, use commercially reasonable efforts to (x) preserve its assets and business organization and maintain its existing relationships with material customers, suppliers, distributors, Governmental Authorities and business partners.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.1 – Conduct of Business by the Company Pending the Merger"
      }
    ]
  },
  "board_approval": {
    "board_approval": [
      {
        "section": "board_approval",
        "field_name": "target_board_approval",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The merger agreement explicitly states that the Company Board has approved the transaction.",
        "clause_text": "The Company Board has, by resolutions unanimously adopted by the Company Board, (i) approved this Agreement and the transactions contemplated by this Agreement, (ii) determined that this Agreement and the transactions contemplated by this Agreement are advisable and in the best interests of the Company and the Company's stockholders.",
        "reference_section": "ARTICLE Article III REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 3.3 Authority Relative to Agreement"
      },
      {
        "section": "board_approval",
        "field_name": "target_board_unanimous",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement specifies that the Company Board's approval was unanimous.",
        "clause_text": "The Company Board has, by resolutions unanimously adopted by the Company Board, (i) approved this Agreement and the transactions contemplated by this Agreement...",
        "reference_section": "ARTICLE Article III REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 3.3 Authority Relative to Agreement"
      },
      {
        "section": "board_approval",
        "field_name": "acquirer_board_approval",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The merger agreement explicitly states that the Parent Board has approved the transaction.",
        "clause_text": "The Parent Board and the Merger Sub Board have, by resolutions unanimously adopted thereby, approved this Agreement and the transactions contemplated by this Agreement.",
        "reference_section": "ARTICLE IV – REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.3 Authority Relative to Agreement"
      },
      {
        "section": "board_approval",
        "field_name": "acquirer_board_unanimous",
        "answer": true,
        "summary": "The Parent Board and the Merger Sub Board have approved the agreement and transactions unanimously.",
        "confidence": 1.0,
        "reason": "The document explicitly states that the Parent Board and the Merger Sub Board have, by resolutions unanimously adopted, approved the agreement.",
        "clause_text": "The Parent Board and the Merger Sub Board have, by resolutions unanimously adopted thereby, approved this Agreement and the transactions contemplated by this Agreement.",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.3 Authority Relative to Agreement"
      }
    ]
  },
  "party_details": {
    "acquirer": [
      {
        "section": "party_details",
        "field_name": "acquirer",
        "answer": "James Hardie Industries plc",
        "summary": "The acquiring entity in the merger is James Hardie Industries plc, an Irish public limited company.",
        "confidence": 0.95,
        "reason": "The agreement explicitly names James Hardie Industries plc as the Parent, which is the acquiring entity.",
        "clause_text": "THIS AGREEMENT AND PLAN OF MERGER (this \"Agreement\"), dated as of March 23, 2025, is made by and among James Hardie Industries plc, an Irish public limited company (\"Parent\"), Juno Merger Sub Inc., a Delaware corporation and a direct or indirect wholly owned Subsidiary of Parent (\"Merger Sub\"), and The AZEK Company Inc., a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      },
      {
        "section": "party_details",
        "field_name": "parent_entity_details",
        "answer": "Parent is a public limited company duly organized and validly existing under the laws of Ireland.",
        "summary": "The ultimate parent company is a public limited company organized under Irish law.",
        "confidence": 0.9,
        "reason": "The document explicitly states that Parent is a public limited company organized under the laws of Ireland, implying it is the ultimate parent entity.",
        "clause_text": "Parent is a public limited company duly organized and validly existing under the laws of Ireland.",
        "reference_section": "ARTICLE IV – REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.1 Organization; Qualification"
      }
    ],
    "target": [
      {
        "section": "party_details",
        "field_name": "target",
        "answer": "The AZEK Company Inc.",
        "summary": "The full legal name of the target company being acquired is 'The AZEK Company Inc.', as defined in the agreement.",
        "confidence": 1.0,
        "reason": "The agreement explicitly defines 'The AZEK Company Inc.' as the Company being acquired.",
        "clause_text": "THIS AGREEMENT AND PLAN OF MERGER (this \"Agreement\"), dated as of March 23, 2025, is made by and among James Hardie Industries plc, an Irish public limited company (\"Parent\"), Juno Merger Sub Inc., a Delaware corporation and a direct or indirect wholly owned Subsidiary of Parent (\"Merger Sub\"), and The AZEK Company Inc., a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "subsidiaries": [
      {
        "section": "party_details",
        "field_name": "target_subsidiaries_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no explicit reference to any subsidiaries of the target company being directly involved in the merger structure.",
        "clause_text": "The obligations of Parent and Merger Sub to effect the Merger are subject to the satisfaction or (to the extent permitted by Law) waiver by Parent at or prior to the Closing of the following additional conditions: (a) each of the representations and warranties of the Company...",
        "reference_section": "ARTICLE Article VI CONDITIONS TO THE MERGER > Section 6.2 Conditions to Obligations of Parent and Merger Sub to Effect the Merger"
      },
      {
        "section": "party_details",
        "field_name": "target_subsidiaries",
        "answer": "No target subsidiaries explicitly involved in the merger structure are mentioned.",
        "summary": "The agreement does not explicitly reference any subsidiaries of the target company as being directly involved in the merger structure.",
        "confidence": 0.9,
        "reason": "The provided excerpts focus on the roles of Parent, Merger Sub, and the Company, without mentioning any specific subsidiaries of the target company in the merger mechanics.",
        "clause_text": "Upon the terms and subject to the conditions of this Agreement, and in accordance with the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company, whereupon the separate existence of Merger Sub shall cease and the Surviving Corporation shall continue as the surviving corporation of the Merger and a direct or indirect wholly owned Subsidiary of Parent.",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.1 The Merger"
      },
      {
        "section": "party_details",
        "field_name": "acquirer_subsidiaries_present",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "Merger Sub, a direct or indirect wholly owned subsidiary of Parent, is explicitly referenced as being directly involved in the merger structure.",
        "clause_text": "Merger Sub is a corporation duly organized and validly existing under the laws of the State of Delaware. Each of Parent and Merger Sub has the requisite corporate power and authority to conduct its business as it is now being conducted and to own, lease and operate its properties and assets in the manner in which its properties and assets are currently operated...",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.1 Organization; Qualification"
      },
      {
        "section": "party_details",
        "field_name": "acquirer_subsidiaries",
        "answer": "[{ \"name\": \"Juno Merger Sub Inc.\", \"clause_reference\": \"ARTICLE Article I THE MERGER > Section 1.1 The Merger\", \"role\": \"Wholly owned merger vehicle used to merge with the target\" }]",
        "summary": "Juno Merger Sub Inc., a wholly owned subsidiary of the Parent, is explicitly involved in the merger structure as the merger vehicle that will merge with the target company.",
        "confidence": 0.95,
        "reason": "The document explicitly states that Merger Sub will merge with the Company, indicating its role as a merger vehicle.",
        "clause_text": "Upon the terms and subject to the conditions of this Agreement, and in accordance with the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company, whereupon the separate existence of Merger Sub shall cease and the Surviving Corporation shall continue as the surviving corporation of the Merger and a direct or indirect wholly owned Subsidiary of Parent.",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.1 The Merger"
      }
    ],
    "transaction": [
      {
        "section": "party_details",
        "field_name": "transaction_type",
        "answer": "Reverse Triangular Merger",
        "summary": "The transaction involves Merger Sub merging with and into the Company, with the Company continuing as the surviving corporation and becoming a wholly owned subsidiary of Parent.",
        "confidence": 0.95,
        "reason": "The structure described matches a Reverse Triangular Merger, where the subsidiary (Merger Sub) merges into the target (Company), and the target survives.",
        "clause_text": "Upon the terms and subject to the conditions of this Agreement, and in accordance with the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company, whereupon the separate existence of Merger Sub shall cease and the Surviving Corporation shall continue as the surviving corporation of the Merger and a direct or indirect wholly owned Subsidiary of Parent.",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.1 The Merger"
      },
      {
        "section": "party_details",
        "field_name": "transaction_structure_notes",
        "answer": "The transaction is structured as a merger where Merger Sub will merge with and into the Company, with the Company continuing as the Surviving Corporation and becoming a wholly owned subsidiary of Parent.",
        "summary": "The transaction involves Merger Sub merging into the Company, resulting in the Company becoming the Surviving Corporation and a wholly owned subsidiary of Parent.",
        "confidence": 0.95,
        "reason": "The structure is clearly outlined with Merger Sub merging into the Company, which will continue as the Surviving Corporation.",
        "clause_text": "Upon the terms and subject to the conditions of this Agreement, and in accordance with the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company, whereupon the separate existence of Merger Sub shall cease and the Surviving Corporation shall continue as the surviving corporation of the Merger and a direct or indirect wholly owned Subsidiary of Parent.",
        "reference_section": "ARTICLE I – THE MERGER > Section 1.1 – The Merger"
      }
    ],
    "merger_sub_details": [
      {
        "section": "party_details",
        "field_name": "merger_sub_details",
        "answer": "Juno Merger Sub Inc., a Delaware corporation and a direct or indirect wholly owned Subsidiary of Parent",
        "summary": "Juno Merger Sub Inc. is a Delaware corporation and a direct or indirect wholly owned subsidiary of the Parent, James Hardie Industries plc.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "THIS AGREEMENT AND PLAN OF MERGER (this \"Agreement\"), dated as of March 23, 2025, is made by and among James Hardie Industries plc, an Irish public limited company (\"Parent\"), Juno Merger Sub Inc., a Delaware corporation and a direct or indirect wholly owned Subsidiary of Parent (\"Merger Sub\"), and The AZEK Company Inc., a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      }
    ]
  },
  "closing_mechanics": {
    "target_date": [
      {
        "section": "closing_mechanics",
        "field_name": "target_date",
        "answer": "3rd Business Day after satisfaction or waiver of conditions in Article VI",
        "summary": "The closing of the Merger is expected to occur no later than the third Business Day after the satisfaction or waiver of the conditions set forth in Article VI, unless otherwise agreed in writing by the parties.",
        "confidence": 0.9,
        "reason": "The clause specifies the closing date as the third Business Day after conditions are met or waived.",
        "clause_text": "Subject to the provisions of Article VI, the closing of the Merger (the \"Closing\") shall take place at 9:00 a.m. (Chicago, Illinois, United States time) on a date to be specified by the parties hereto, but no later than the third (3rd) Business Day after the satisfaction or waiver of the conditions set forth in Article VI...",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.2 The Closing"
      }
    ],
    "marketing_period": [
      {
        "section": "closing_mechanics",
        "field_name": "has_marketing_period",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The term 'Marketing Period' is not mentioned or explicitly referenced in connection with financing, deliverables, or closing timing in the provided excerpts.",
        "clause_text": "The provided excerpts do not contain any reference to a 'Marketing Period'.",
        "reference_section": "Not applicable as the term is absent in the provided sections."
      },
      {
        "section": "closing_mechanics",
        "field_name": "marketing_period_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "inside_date": [
      {
        "section": "closing_mechanics",
        "field_name": "has_inside_date",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not explicitly define or reference an 'Inside Date' as a deadline or milestone prior to the Outside Date.",
        "clause_text": "Notwithstanding anything contained in this Agreement to the contrary, this Agreement may be terminated at any time prior to the Effective Time, whether before or after the Company Stockholder Approval is obtained (except as otherwise expressly noted), as follows: (a) by mutual written consent of each of Parent and the Company; (b) by either Parent or the Company, if: (i) the Merger shall not have been consummated on or before 5:00 p.m. (Chicago, Illinois, United States time) on the twelve (12)-month anniversary of the date of this Agreement (the 'Termination Date');",
        "reference_section": "ARTICLE Article VII TERMINATION, AMENDMENT AND WAIVER > Section 7.1 Termination"
      },
      {
        "section": "closing_mechanics",
        "field_name": "inside_date_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "specific_performance": {
    "specific_performance": [
      {
        "section": "specific_performance",
        "field_name": "specific_performance_available",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement expressly states that the parties are entitled to specific performance as a remedy.",
        "clause_text": "Accordingly, the parties acknowledge and agree that, prior to any termination of this Agreement in accordance with Section 7.1, the parties shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.11 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_parties",
        "answer": "the parties",
        "summary": "The parties to the agreement are entitled to seek specific performance to prevent breaches and enforce the terms of the agreement.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that the parties are entitled to seek specific performance.",
        "clause_text": "Accordingly, the parties acknowledge and agree that, prior to any termination of this Agreement in accordance with Section 7.1, the parties shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.11 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_limitations",
        "answer": "There are no specific limitations or conditions imposed on the right to seek specific performance related to financing or other thresholds.",
        "summary": "The agreement allows parties to seek specific performance without requiring a bond or other security, and does not impose conditions related to financing.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that parties can seek specific performance without opposition or the need for a bond, and no conditions related to financing are mentioned.",
        "clause_text": "Accordingly, the parties acknowledge and agree that, prior to any termination of this Agreement in accordance with Section 7.1, the parties shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.11 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_financing_condition",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document explicitly states that the obligations of Parent and Merger Sub are not subject to any condition regarding the ability to obtain financing.",
        "clause_text": "The obligations of Parent and Merger Sub hereunder are not subject to any condition regarding Parent's, Merger Sub's or any other Person's ability to obtain financing (including the Financing) for the Merger and the other transactions contemplated by this Agreement.",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.25 Financing"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_financing_details",
        "answer": "The obligations of Parent and Merger Sub are not subject to any condition regarding their ability to obtain financing for the Merger.",
        "summary": "The agreement specifies that the obligations of Parent and Merger Sub are not contingent upon obtaining financing, indicating that specific performance is not conditioned on financing.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that obtaining financing is not a condition to the obligations of Parent and Merger Sub.",
        "clause_text": "The obligations of Parent and Merger Sub hereunder are not subject to any condition regarding Parent's, Merger Sub's or any other Person's ability to obtain financing (including the Financing) for the Merger and the other transactions contemplated by this Agreement.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.15 – Financing and Financing Cooperation > (c)"
      }
    ]
  },
  "confidentiality_and_clean_room": {
    "confidentiality": [
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly references a confidentiality agreement between the parties.",
        "clause_text": "Confidentiality Agreement shall mean the confidentiality agreement, dated January 23, 2025, between Parent and the Company.",
        "reference_section": "Definition > Confidentiality Agreement"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_agreement_date",
        "answer": "January 23, 2025",
        "summary": "The confidentiality agreement was signed on January 23, 2025, between Parent and the Company.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Confidentiality Agreement shall mean the confidentiality agreement, dated January 23, 2025, between Parent and the Company.",
        "reference_section": "Definition > Confidentiality Agreement"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_obligation_termination_date",
        "answer": "The confidentiality obligations are perpetual and extend post-termination.",
        "summary": "The Confidentiality Agreement shall survive any termination of this Agreement pursuant to Section 7.1, indicating that confidentiality obligations are perpetual and extend beyond termination.",
        "confidence": 0.9,
        "reason": "The language in Section 7.2 explicitly states that the Confidentiality Agreement survives termination, implying perpetual obligations.",
        "clause_text": "provided, further, that the Confidentiality Agreement, the penultimate sentence of Section 5.15(c), this Section 7.2, Section 7.3, Section 7.4, Section 7.5 and Article VIII shall survive any termination of this Agreement pursuant to Section 7.1.",
        "reference_section": "ARTICLE Article VII TERMINATION, AMENDMENT AND WAIVER > Section 7.2 Effect of Termination"
      }
    ],
    "clean_room": [
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no reference to a Clean Room or Clean Team arrangement in the provided excerpts.",
        "clause_text": "No relevant text found in the provided excerpts.",
        "reference_section": "confidentiality_and_clean_room > clean_room"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_start_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_end_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_scope_restrictions",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_protection_clause_present",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement includes a clause that requires the Company to terminate access to any data room set up for a possible Acquisition Proposal, which implies restriction of access to confidential data in connection with a Superior Proposal.",
        "clause_text": "the Company shall not provide and shall, within one (1) Business Day of the date of this Agreement, terminate access of any third party to any data room (virtual or actual) which has been set up in the context of a possible Acquisition Proposal containing any information of the Company or any of its Subsidiaries",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (a) > (iii)"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_protection_clause_summary",
        "answer": "The agreement contains a provision that results in the suspension of the Company's access to clean room or confidential information in connection with a Superior Proposal.",
        "summary": "The Company must terminate third-party access to any data room related to an Acquisition Proposal and demand the return or destruction of all confidential information provided to third parties within one business day of the agreement date.",
        "confidence": 0.9,
        "reason": "The clause specifies actions to restrict access and handle confidential information upon receiving an Acquisition Proposal.",
        "clause_text": "The Company shall not provide and shall, within one (1) Business Day of the date of this Agreement, terminate access of any third party to any data room (virtual or actual) which has been set up in the context of a possible Acquisition Proposal containing any information of the Company or any of its Subsidiaries and (iv) within one (1) Business Day of the date of this Agreement, the Company shall demand the return or destruction of all confidential, non-public information and materials that have been provided to third parties that have entered into confidentiality agreements relating to a possible Acquisition Proposal with the Company or any of its Subsidiaries.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (a)"
      }
    ]
  },
  "complex_consideration_and_dividends": {
    "deal_consideration": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "deal_consideration_overview",
        "answer": "$26.45 per share in cash and a number of Parent Shares equal to the Exchange Ratio",
        "summary": "The total consideration offered to target shareholders includes $26.45 per share in cash and a number of validly issued, fully paid, and nonassessable Parent Shares equal to the Exchange Ratio.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than Canceled Shares and Dissenting Shares) shall be automatically canceled and converted into the right to receive, in accordance with the terms of this Agreement (A) $26.45 per share in cash, without interest, from Parent (such amount of cash, the \"Cash Consideration\"), and (B) a number of validly issued, fully paid and nonassessable shares, par value EUR 0.59 per share, of Parent (the \"Parent Shares\") equal to the Exchange Ratio.",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (a) > (ii)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "deal_consideration_details",
        "answer": "$26.45 per share in cash and a number of Parent Shares equal to the Exchange Ratio, with cash in lieu of fractional shares.",
        "summary": "The merger consideration includes $26.45 per share in cash and a number of Parent Shares equal to the Exchange Ratio, with cash provided in lieu of fractional shares.",
        "confidence": 0.95,
        "reason": "The document explicitly states the components of the merger consideration, including cash per share and stock exchange ratios.",
        "clause_text": "Each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than Canceled Shares and Dissenting Shares) shall be automatically canceled and converted into the right to receive, in accordance with the terms of this Agreement (A) $26.45 per share in cash, without interest, from Parent (such amount of cash, the 'Cash Consideration'), and (B) a number of validly issued, fully paid and nonassessable shares, par value EUR 0.59 per share, of Parent (the 'Parent Shares') equal to the Exchange Ratio (and, if applicable, cash in lieu of fractional Parent Shares payable in accordance with Section 2.1(c)).",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (a) > (ii)"
      }
    ],
    "proration": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "proration_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement provides for both cash and stock as forms of consideration, indicating proration between different types of consideration.",
        "clause_text": "Each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than Canceled Shares and Dissenting Shares) shall be automatically canceled and converted into the right to receive, in accordance with the terms of this Agreement (A) $26.45 per share in cash, without interest, from Parent (such amount of cash, the 'Cash Consideration'), and (B) a number of validly issued, fully paid and nonassessable shares, par value EUR 0.59 per share, of Parent (the 'Parent Shares') equal to the Exchange Ratio.",
        "reference_section": "ARTICLE II – Effect of the Merger on Capital Stock; Exchange of Certificates > Section 2.1 – Effect on Securities > (a) > (ii)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "proration_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "election": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "election_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no explicit language allowing shareholders to elect among different types of consideration.",
        "clause_text": "Each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than Canceled Shares and Dissenting Shares) shall be automatically canceled and converted into the right to receive, in accordance with the terms of this Agreement (A) $26.45 per share in cash, without interest, from Parent (such amount of cash, the 'Cash Consideration'), and (B) a number of validly issued, fully paid and nonassessable shares, par value EUR 0.59 per share, of Parent (the 'Parent Shares') equal to the Exchange Ratio.",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (a) > (ii)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "election_details",
        "answer": "No election is permitted and consideration is fixed.",
        "summary": "Shareholders are not allowed to choose the form of consideration; each share of Company Common Stock is automatically canceled and converted into the right to receive a fixed combination of cash and Parent Shares.",
        "confidence": 0.95,
        "reason": "The agreement specifies a fixed consideration of cash and Parent Shares for each share of Company Common Stock, with no mention of an election process for shareholders.",
        "clause_text": "Each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than Canceled Shares and Dissenting Shares) shall be automatically canceled and converted into the right to receive, in accordance with the terms of this Agreement (A) $26.45 per share in cash, without interest, from Parent (such amount of cash, the 'Cash Consideration'), and (B) a number of validly issued, fully paid and nonassessable shares, par value EUR 0.59 per share, of Parent (the 'Parent Shares') equal to the Exchange Ratio.",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (a) > (ii)"
      }
    ],
    "cvr": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "cvr_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no mention of a Contingent Value Right (CVR) in the merger consideration described in the document.",
        "clause_text": "Each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than Canceled Shares and Dissenting Shares) shall be automatically canceled and converted into the right to receive, in accordance with the terms of this Agreement (A) $26.45 per share in cash, without interest, from Parent (such amount of cash, the 'Cash Consideration'), and (B) a number of validly issued, fully paid and nonassessable shares, par value EUR 0.59 per share, of Parent (the 'Parent Shares') equal to the Exchange Ratio.",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "cvr_details",
        "answer": "NA",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "ticking_fees": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "ticking_fees_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no mention of any ticking fee, time-based fee, or incremental increase in consideration payable over time due to delay in the provided excerpts.",
        "clause_text": "No investment banker, broker or finder other than Goldman Sachs & Co. LLC, the fees and expenses of which will be paid by the Company, is entitled to any investment banking, brokerage, finder's or similar fee or commission in connection with this Agreement or the transactions contemplated by this Agreement based upon arrangements made by or on behalf of the Company or any of its Affiliates.",
        "reference_section": "ARTICLE Article III REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 3.24 Brokers"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "ticking_fees_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "contingent_payments": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "contingent_payments_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no mention of contingent payments beyond CVRs in the provided document excerpts.",
        "clause_text": "The provided document excerpts do not mention any contingent payments beyond CVRs.",
        "reference_section": "complex_consideration_and_dividends > contingent_payments"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "contingent_payments_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "company_dividends": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "company_dividends_can_pay",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document explicitly prohibits the Company from declaring or paying any dividends or other distributions with respect to its capital stock, except for cash dividends and distributions paid by wholly owned Subsidiaries to the Company or its Subsidiaries.",
        "clause_text": "The Company shall not, and shall cause its Subsidiaries not to, directly or indirectly: (d) declare, set aside, authorize, make or pay any dividend or other distribution, payable in cash, stock, property or otherwise, with respect to the Company's or any of its Subsidiaries' capital stock or other equity interests, other than cash dividends and distributions paid by any direct or indirect wholly owned Subsidiary of the Company to the Company or any direct or indirect wholly owned Subsidiary of the Company;",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.1 – Conduct of Business by the Company Pending the Merger > (B) > (d)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "company_dividends_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "parent_dividends": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "parent_dividends_can_pay",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document explicitly states that the Parent shall not declare, authorize, make or pay any dividend or other distribution with respect to its capital stock or other equity interests before closing.",
        "clause_text": "Parent shall not, directly or indirectly: (e) declare, authorize, make or pay any dividend or other distribution, payable in cash, stock, property or otherwise, with respect to its capital stock or other equity interests;",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.2 – Conduct of Business by Parent Pending the Merger > (B) > (e)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "parent_dividends_details",
        "answer": "Dividends on Parent Shares issued in exchange for Company Common Stock are payable without interest at the time of delivery of such shares by the Exchange Agent, provided the record date is after the Effective Time. Dividends with a record date after the Effective Time but before delivery are paid on the appropriate payment date.",
        "summary": "Dividends on Parent Shares issued in exchange for Company Common Stock are payable without interest at the time of delivery of such shares by the Exchange Agent, provided the record date is after the Effective Time. Dividends with a record date after the Effective Time but before delivery are paid on the appropriate payment date.",
        "confidence": 0.9,
        "reason": "The clause specifies the timing and conditions under which dividends are paid on Parent Shares issued in the merger.",
        "clause_text": "Subject to applicable Law, there shall be paid to the holder of the Parent Shares issued in exchange for Certificates or Book-Entry Shares pursuant to Section 2.2(c), without interest, (i) at the time of delivery of such Parent Shares by the Exchange Agent pursuant to Section 2.2(c), the amount of dividends or other distributions, if any, with a record date after the Effective Time theretofore paid with respect to such Parent Shares, and (ii) at the appropriate payment date, the amount of dividends or other distributions, if any, with a record date after the Effective Time but prior to such delivery of such Parent Shares by the Exchange Agent pursuant to Section 2.2(c), and a payment date subsequent to such delivery of such Parent Shares by the Exchange Agent pursuant to Section 2.2(c), payable with respect to such Parent Shares.",
        "reference_section": "ARTICLE II – Effect of the Merger on Capital Stock; Exchange of Certificates > Section 2.2 Exchange of Certificates > (d)"
      }
    ],
    "collar": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "collar_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no mention of a collar provision adjusting the exchange ratio based on acquirer stock price movements.",
        "clause_text": "Exchange Ratio shall mean 1.0340.",
        "reference_section": "Definition > Exchange Ratio"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "collar_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "exchange_ratio_adjustment": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_adjustment_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly provides for adjustments to the Exchange Ratio based on structural changes such as stock splits or stock dividends.",
        "clause_text": "Without limiting the other provisions of this Agreement, if at any time during the period between the date of this Agreement and the Effective Time, any change in the number or type of outstanding Parent Shares or Company Common Stock shall occur as a result of a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of shares or any stock dividend or stock distribution with a record date during such period, the Merger Consideration, the Exchange Ratio and any other similarly dependent items, as the case may be, shall be appropriately adjusted to provide the same economic effect as contemplated by this Agreement prior to such event.",
        "reference_section": "ARTICLE II – Effect of the Merger on Capital Stock; Exchange of Certificates > Section 2.1 Effect on Securities > (b)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_adjustment",
        "answer": "The exchange ratio adjustment mechanism includes adjustments for changes in the number or type of outstanding Parent Shares or Company Common Stock due to events like reclassification, recapitalization, stock splits, or stock dividends. The Exchange Ratio is set at 1.0340.",
        "summary": "The exchange ratio is subject to adjustment for changes in the number or type of shares due to events such as stock splits or dividends, ensuring the same economic effect as initially contemplated.",
        "confidence": 0.9,
        "reason": "The agreement specifies adjustments to maintain economic equivalence in case of share changes.",
        "clause_text": "if at any time during the period between the date of this Agreement and the Effective Time, any change in the number or type of outstanding Parent Shares or Company Common Stock shall occur as a result of a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of shares or any stock dividend or stock distribution with a record date during such period, the Merger Consideration, the Exchange Ratio and any other similarly dependent items, as the case may be, shall be appropriately adjusted to provide the same economic effect as contemplated by this Agreement prior to such event.",
        "reference_section": "ARTICLE II – Effect of the Merger on Capital Stock; Exchange of Certificates > Section 2.1 Effect on Securities > (b)"
      }
    ],
    "dividend_adjustment_mechanism": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "dividend_adjustment_mechanism_exists",
        "answer": true,
        "summary": "The merger consideration adjusts based on dividends or distributions prior to closing, including stock dividends.",
        "confidence": 0.95,
        "reason": "The document specifies that the Merger Consideration and Exchange Ratio will be adjusted for stock dividends or distributions with a record date during the period between the date of the Agreement and the Effective Time.",
        "clause_text": "if at any time during the period between the date of this Agreement and the Effective Time, any change in the number or type of outstanding Parent Shares or Company Common Stock shall occur as a result of a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of shares or any stock dividend or stock distribution with a record date during such period, the Merger Consideration, the Exchange Ratio and any other similarly dependent items, as the case may be, shall be appropriately adjusted to provide the same economic effect as contemplated by this Agreement prior to such event.",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (b)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "dividend_adjustment_mechanism",
        "answer": "The merger consideration adjusts if dividends are paid before closing by either party through an appropriate adjustment to the Merger Consideration, the Exchange Ratio, and any other similarly dependent items to provide the same economic effect as contemplated by the Agreement prior to such event.",
        "summary": "The merger consideration will be adjusted to maintain the same economic effect if any stock dividend or stock distribution occurs before the closing.",
        "confidence": 0.9,
        "reason": "The clause specifies adjustments to maintain economic equivalence if stock dividends or distributions occur.",
        "clause_text": "if at any time during the period between the date of this Agreement and the Effective Time, any change in the number or type of outstanding Parent Shares or Company Common Stock shall occur as a result of a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of shares or any stock dividend or stock distribution with a record date during such period, the Merger Consideration, the Exchange Ratio and any other similarly dependent items, as the case may be, shall be appropriately adjusted to provide the same economic effect as contemplated by this Agreement prior to such event.",
        "reference_section": "ARTICLE II – Effect of the Merger on Capital Stock; Exchange of Certificates > Section 2.1 Effect on Securities > (b)"
      }
    ]
  },
  "law_and_jurisdiction": {
    "governing_law": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "governing_law_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that it is governed by the laws of the State of Delaware and, for certain matters, the laws of the State of New York.",
        "clause_text": "This Agreement and all Proceedings ... shall be governed by, and construed in accordance with, the Laws of the State of Delaware ... all matters relating to any action or claim against any Financing Source Party ... shall be exclusively governed by, and construed in accordance with, the Laws of the State of New York.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.10 Governing Law"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "governing_law_jurisdiction",
        "answer": "Delaware",
        "summary": "The agreement specifies that it shall be governed by the laws of the State of Delaware, excluding any choice or conflict of laws provisions.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "This Agreement and all Proceedings (whether based in contract, tort or otherwise) arising out of or relating to this Agreement or the actions of Parent, Merger Sub or the Company in the negotiation, administration, performance and enforcement hereof, shall be governed by, and construed in accordance with, the Laws of the State of Delaware, without giving effect to any choice or conflict of laws provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware...",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.10 Governing Law"
      }
    ],
    "mae_interpretation_jurisdiction": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "mae_interpretation_jurisdiction_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not specify that the interpretation of Material Adverse Effect (MAE) is to be construed under a specific jurisdiction or legal standard.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred...",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "mae_interpretation_jurisdiction",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "financing_jurisdiction": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_jurisdiction_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement specifies that disputes related to the Financing must be brought in state or Federal court sitting in the county of New York.",
        "clause_text": "each party agrees that it will not bring or support any action, cause of action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Financing Source Parties in any way relating to this Agreement or any of the transactions contemplated by this Agreement, including any dispute arising out of or relating in any way to the Financing or the performance thereof, in any forum other than any state or Federal court sitting in the county of New York.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.12 Consent to Jurisdiction > (c)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_jurisdiction",
        "answer": "New York",
        "summary": "All matters relating to any action or claim against any Financing Source Party, and all matters relating to the interpretation, construction, validity and enforcement against any of the Financing Source Parties in any way relating to the Debt Letters or the performance thereof or the Financing, shall be exclusively governed by the Laws of the State of New York.",
        "confidence": 0.9,
        "reason": "The document specifies that financing-related matters are governed by the laws of the State of New York.",
        "clause_text": "all matters relating to any action or claim against any Financing Source Party, and all matters relating to the interpretation, construction, validity and enforcement (whether at law, in equity, in contract, in tort, or otherwise) against any of the Financing Source Parties in anyway relating to the Debt Letters or the performance thereof or the Financing, shall be exclusively governed by, and construed in accordance with, the Laws of the State of New York.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.10 Governing Law"
      }
    ],
    "arbitration_clause": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "arbitration_clause_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document specifies exclusive jurisdiction in Delaware courts for disputes, with no mention of arbitration.",
        "clause_text": "Each of the parties hereto hereby, with respect to any legal claim or Proceeding arising out of this Agreement or the transactions contemplated by this Agreement, (i) expressly and irrevocably submits, for itself and with respect to its property, generally and unconditionally, to the exclusive jurisdiction of the Delaware Court of Chancery and any appellate court therefrom within the State of Delaware...",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.12 Consent to Jurisdiction"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "arbitration_clause",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "financing": {
    "committed_financing": [
      {
        "section": "financing",
        "field_name": "committed_financing_present",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly mentions committed financing through a commitment letter and Debt Letters.",
        "clause_text": "Parent has delivered to the Company true and complete fully executed copies of (a) the commitment letter, dated as of the date hereof, among JH North America Holdings Inc., a Delaware corporation and a wholly owned indirect Subsidiary of Parent (the 'Borrower'), and Bank of America, N.A. and Jeffries Finance LLC (together, the 'Initial Lenders')... (collectively, the 'Debt Letters'), pursuant to which and subject to the terms and conditions thereof each of the Initial Lenders party thereto have severally committed to lend the amounts set forth therein to the Borrower...",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.25 Financing"
      },
      {
        "section": "financing",
        "field_name": "committed_financing_summary",
        "answer": "The committed financing arrangements include a debt commitment from Bank of America, N.A. and Jeffries Finance LLC, who are the Initial Lenders. They have committed to lend the amounts set forth in the Debt Letters to JH North America Holdings Inc., a wholly owned indirect subsidiary of Parent, for the purposes set forth in such Debt Letters.",
        "summary": "The committed financing involves debt from Bank of America, N.A. and Jeffries Finance LLC to JH North America Holdings Inc., a subsidiary of Parent.",
        "confidence": 0.9,
        "reason": "The commitment letter and the identity of the lenders are explicitly mentioned, indicating a clear debt financing arrangement.",
        "clause_text": "Parent has delivered to the Company true and complete fully executed copies of (a) the commitment letter, dated as of the date hereof, among JH North America Holdings Inc., a Delaware corporation and a wholly owned indirect Subsidiary of Parent (the 'Borrower'), and Bank of America, N.A. and Jeffries Finance LLC (together, the 'Initial Lenders')...",
        "reference_section": "ARTICLE IV – Representations and Warranties of Parent and Merger Sub > Section 4.25 Financing"
      }
    ],
    "financing_efforts_summary": [
      {
        "section": "financing",
        "field_name": "financing_efforts_summary",
        "answer": "Parent is obligated to use reasonable best efforts to consummate the Financing, maintain the Debt Letters, comply with obligations, and ensure the Financing is sufficient for the Merger.",
        "summary": "Parent is obligated to use reasonable best efforts to consummate the Financing, maintain the Debt Letters, comply with obligations, and ensure the Financing is sufficient for the Merger.",
        "confidence": 0.9,
        "reason": "The clause explicitly states Parent's obligations to use reasonable best efforts to secure financing and maintain the Debt Letters.",
        "clause_text": "Parent shall, and shall cause its Subsidiaries (including the Borrower) to, use reasonable best efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things reasonably necessary to consummate the Financing in an amount sufficient, together with cash on hand and amounts available to be drawn on the Parent Credit Facilities, to consummate the Merger and the other transactions contemplated hereby no later than the Closing.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.15 – Financing and Financing Cooperation > (a)"
      }
    ],
    "substitute_financing_notice_and_efforts": [
      {
        "section": "financing",
        "field_name": "substitute_financing_notice_and_efforts",
        "answer": "The acquirer is required to notify the company if financing becomes unavailable and must use reasonable best efforts to obtain substitute financing.",
        "summary": "The acquirer must notify the company in writing if financing becomes unavailable and use reasonable best efforts to secure substitute financing on terms not materially less favorable.",
        "confidence": 0.9,
        "reason": "The clause explicitly requires notification and efforts to secure substitute financing if the original financing becomes unavailable.",
        "clause_text": "If funds in the amounts set forth in the Debt Letters, or any portion thereof, become unavailable, Parent shall, and shall cause its Subsidiaries to, as promptly as practicable following the occurrence of such event (x) notify the Company in writing thereof and (y) use reasonable best efforts to obtain substitute financing...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.15 – Financing and Financing Cooperation > (b)"
      }
    ]
  },
  "proxy_statement": {
    "proxy_statement_filing_timing": [
      {
        "section": "proxy_statement",
        "field_name": "proxy_statement_filing_timing",
        "answer": "As promptly as reasonably practicable after the execution of this Agreement",
        "summary": "The proxy statement and Form F-4 must be filed with the SEC as promptly as reasonably practicable after the execution of the agreement.",
        "confidence": 0.9,
        "reason": "The clause specifies the timing for filing the Proxy Statement and Form F-4 as 'as promptly as reasonably practicable' after the agreement's execution.",
        "clause_text": "As promptly as reasonably practicable after the execution of this Agreement, (i) the Company (with Parent's reasonable cooperation) shall prepare and file with the SEC the Proxy Statement in preliminary form and (ii) Parent (with the Company's reasonable cooperation) shall prepare and file with the SEC a registration statement on Form F-4.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (a)"
      }
    ],
    "f4_effectiveness": [
      {
        "section": "proxy_statement",
        "field_name": "f4_effectiveness_efforts",
        "answer": "reasonable best efforts",
        "summary": "The parties must use their reasonable best efforts to make the Form F-4 effective as promptly as reasonably practicable, including preparing and filing necessary documents and obtaining required approvals.",
        "confidence": 0.9,
        "reason": "The agreement specifies 'reasonable best efforts' and 'as promptly as reasonably practicable' for making the Form F-4 effective.",
        "clause_text": "Subject to the terms and conditions of this Agreement, the parties hereto will cooperate with each other and use (and will cause their respective Subsidiaries to use) their respective reasonable best efforts to consummate the transactions contemplated by this Agreement and to cause the conditions to the Merger set forth in Article VI to be satisfied as promptly as reasonably practicable, including using reasonable best efforts to accomplish the following as promptly as reasonably practicable...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "proxy_statement",
        "field_name": "f4_effectiveness_target_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "shareholder_meeting": [
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_timing",
        "answer": "within 50 days of the effectiveness of the Form F-4",
        "summary": "The shareholder meeting is expected to be held within 50 days following the effectiveness of the Form F-4.",
        "confidence": 0.9,
        "reason": "The document specifies that the Company Stockholders' Meeting shall be held within 50 days of the effectiveness of the Form F-4.",
        "clause_text": "Subject to the earlier termination of this Agreement in accordance with Section 7.1, the Company shall, as soon as reasonably practicable following the effectiveness of the Form F-4, duly call, give notice of, convene (on a date selected by the Company in consultation with Parent, which date shall be within, subject to adjournment or postponement as provided below, fifty (50) days of the effectiveness of the Form F-4) and hold a meeting of its stockholders (the \"Company Stockholders' Meeting\") for the purpose of seeking the Company Stockholder Approval.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_deadline",
        "answer": "50 days",
        "summary": "The shareholder meeting must be held within 50 days of the effectiveness of the Form F-4, subject to adjournment or postponement.",
        "confidence": 0.9,
        "reason": "The document specifies a 50-day limit for holding the shareholder meeting after the Form F-4 becomes effective.",
        "clause_text": "Subject to the earlier termination of this Agreement in accordance with Section 7.1, the Company shall, as soon as reasonably practicable following the effectiveness of the Form F-4, duly call, give notice of, convene (on a date selected by the Company in consultation with Parent, which date shall be within, subject to adjournment or postponement as provided below, fifty (50) days of the effectiveness of the Form F-4) and hold a meeting of its stockholders (the \"Company Stockholders' Meeting\") for the purpose of seeking the Company Stockholder Approval...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_vote_efforts",
        "answer": "reasonable best efforts",
        "summary": "The company is required to use its reasonable best efforts to solicit proxies and secure shareholder approval for the merger.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the company's obligation to use reasonable best efforts to solicit proxies and secure shareholder approval.",
        "clause_text": "If the Company Board has not made an Adverse Recommendation Change in accordance with Section 5.6, the Company shall, through the Company Board, make the Company Recommendation, and shall include such Company Recommendation in the Proxy Statement, and use its reasonable best efforts to (A) solicit from its stockholders proxies in favor of the adoption of this Agreement and (B) take all other action necessary or advisable to secure the Company Stockholder Approval.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      }
    ],
    "quorum_or_vote_failure": [
      {
        "section": "proxy_statement",
        "field_name": "quorum_or_vote_failure_handling",
        "answer": "If the meeting fails to reach quorum or shareholder approval, the Company may adjourn or postpone the meeting to allow additional time for solicitation of proxies to obtain a quorum or shareholder approval, for a period of no more than twenty-five business days in the aggregate, unless it would require a change to the record date.",
        "summary": "The Company can adjourn or postpone the stockholders' meeting to solicit more proxies if quorum or approval is not met, limited to 25 business days unless it changes the record date.",
        "confidence": 0.9,
        "reason": "The agreement specifies procedures for adjournment or postponement if quorum or shareholder approval is not achieved.",
        "clause_text": "the Company may adjourn or postpone the Company Stockholders' Meeting (i) after consultation with Parent, to the extent necessary to ensure that any supplement or amendment to the Proxy Statement or Form F-4 required by Law is provided to the stockholders of the Company within a reasonable amount of time in advance of the Company Stockholders' Meeting or (ii) if there are not sufficient affirmative votes in person or by proxy at such meeting to constitute a quorum at the Company Stockholders' Meeting or to obtain the Company Stockholder Approval, to allow reasonable additional time for solicitation of proxies for purposes of obtaining a quorum or the Company Stockholder Approval; provided, however, that unless agreed to in writing by Parent, any such adjournments or postponements under this clause (ii) shall be for a period of no more than twenty-five (25) Business Days in the aggregate; provided, further, that the Company shall not postpone the Company Stockholders' Meeting as contemplated by this clause (ii) if it would require a change to the record date for the Company Stockholders' Meeting;",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      },
      {
        "section": "proxy_statement",
        "field_name": "quorum_or_vote_failure_deadline",
        "answer": "twenty-five (25) Business Days",
        "summary": "The Company may adjourn or postpone the Company Stockholders' Meeting for a period of no more than twenty-five (25) Business Days in the aggregate to allow reasonable additional time for solicitation of proxies for purposes of obtaining a quorum or the Company Stockholder Approval.",
        "confidence": 0.9,
        "reason": "The document specifies a maximum period for adjournments or postponements related to obtaining a quorum or stockholder approval.",
        "clause_text": "provided, however, that unless agreed to in writing by Parent, any such adjournments or postponements under this clause (ii) shall be for a period of no more than twenty-five (25) Business Days in the aggregate;",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      }
    ],
    "proxy_summary_notes": [
      {
        "section": "proxy_statement",
        "field_name": "proxy_summary_notes",
        "answer": "The Company must call a stockholders' meeting within 50 days of the Form F-4's effectiveness, with specific conditions for adjournment or postponement.",
        "summary": "The Company is required to convene a stockholders' meeting within 50 days of the Form F-4's effectiveness, with limited conditions for adjournment or postponement, such as ensuring legal compliance or obtaining sufficient votes.",
        "confidence": 0.9,
        "reason": "The agreement specifies a 50-day timeline for the stockholders' meeting and outlines conditions under which the meeting can be postponed or adjourned.",
        "clause_text": "the Company shall, as soon as reasonably practicable following the effectiveness of the Form F-4, duly call, give notice of, convene (on a date selected by the Company in consultation with Parent, which date shall be within, subject to adjournment or postponement as provided below, fifty (50) days of the effectiveness of the Form F-4) and hold a meeting of its stockholders",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      }
    ]
  },
  "timeline": {
    "agreement_signing_date": [
      {
        "section": "timeline",
        "field_name": "agreement_signing_date",
        "answer": "March 23, 2025",
        "summary": "The merger agreement was officially signed on March 23, 2025, as indicated in the preamble of the document.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "THIS AGREEMENT AND PLAN OF MERGER (this \"Agreement\"), dated as of March 23, 2025, is made by and among James Hardie Industries plc, an Irish public limited company (\"Parent\"), Juno Merger Sub Inc., a Delaware corporation and a direct or indirect wholly owned Subsidiary of Parent (\"Merger Sub\"), and The AZEK Company Inc., a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "confidentiality_agreement_signing_date": [
      {
        "section": "timeline",
        "field_name": "confidentiality_agreement_signing_date",
        "answer": "January 23, 2025",
        "summary": "The confidentiality agreement related to the merger was signed on January 23, 2025, between Parent and the Company.",
        "confidence": 1.0,
        "reason": "The date is explicitly stated in the definition of the Confidentiality Agreement.",
        "clause_text": "Confidentiality Agreement shall mean the confidentiality agreement, dated January 23, 2025, between Parent and the Company.",
        "reference_section": "Definition > Confidentiality Agreement"
      }
    ],
    "announcement_date": [
      {
        "section": "timeline",
        "field_name": "announcement_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "proxy_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "proxy_filing_deadline",
        "answer": "As promptly as reasonably practicable after the execution of this Agreement",
        "summary": "The preliminary proxy statement and/or registration statement on Form F-4 must be filed as promptly as reasonably practicable after the execution of the agreement.",
        "confidence": 0.9,
        "reason": "The clause specifies that the filing should occur 'as promptly as reasonably practicable' after the agreement's execution.",
        "clause_text": "As promptly as reasonably practicable after the execution of this Agreement, (i) the Company (with Parent's reasonable cooperation) shall prepare and file with the SEC the Proxy Statement in preliminary form and (ii) Parent (with the Company's reasonable cooperation) shall prepare and file with the SEC a registration statement on Form F-4.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (a)"
      }
    ],
    "shareholder_vote_deadline": [
      {
        "section": "timeline",
        "field_name": "shareholder_vote_deadline",
        "answer": "50 days after the effectiveness of the Form F-4",
        "summary": "The shareholder vote must occur within 50 days of the effectiveness of the Form F-4, subject to possible adjournment or postponement.",
        "confidence": 0.9,
        "reason": "The document specifies a timeline for the shareholder vote relative to the Form F-4 effectiveness.",
        "clause_text": "the Company shall, as soon as reasonably practicable following the effectiveness of the Form F-4, duly call, give notice of, convene (on a date selected by the Company in consultation with Parent, which date shall be within, subject to adjournment or postponement as provided below, fifty (50) days of the effectiveness of the Form F-4) and hold a meeting of its stockholders",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      }
    ],
    "outside_date": [
      {
        "section": "timeline",
        "field_name": "outside_date",
        "answer": "5:00 p.m. (Chicago, Illinois, United States time) on the twelve (12)-month anniversary of the date of this Agreement",
        "summary": "The initial Outside Date is specified as the twelve-month anniversary of the date of the Agreement, allowing either party to terminate if the merger has not closed by this time.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "by either Parent or the Company, if: (i) the Merger shall not have been consummated on or before 5:00 p.m. (Chicago, Illinois, United States time) on the twelve (12)-month anniversary of the date of this Agreement (the \"Termination Date\");",
        "reference_section": "ARTICLE Article VII TERMINATION, AMENDMENT AND WAIVER > Section 7.1 Termination"
      },
      {
        "section": "timeline",
        "field_name": "outside_date_extension_list",
        "answer": "1. Extension Length – 3 months; Who Grants the Extension – Automatic; Conditions to Extend – Conditions to Closing in Section 6.1(d) or Section 6.1(e) (if the Restraint is in respect of an Antitrust Law) not satisfied, but all other conditions in Section 6.1 through Section 6.3 satisfied or waived; Termination Restrictions Due to Breach – Yes, the right to terminate is not available to a party if their material breach was the principal cause of the failure to close by the outside date.",
        "summary": "The Termination Date may be automatically extended by 3 months if certain conditions related to regulatory approvals are not met, provided all other conditions are satisfied or waived. Termination rights are restricted if a party's material breach caused the failure to close.",
        "confidence": 0.95,
        "reason": "The agreement specifies an automatic extension under certain conditions and restricts termination rights if a party's breach caused the delay.",
        "clause_text": "provided that if, on the Termination Date, any of the conditions to Closing set forth in Section 6.1(d) or Section 6.1(e) (if the Restraint is in respect of an Antitrust Law) shall not have been satisfied, but all other conditions set forth in Section 6.1 through Section 6.3 shall have been satisfied or waived...the Termination Date shall automatically...be extended for three (3) months...the right to terminate this Agreement...shall not be available to any party if a material breach by such party...has been the principal cause of or principally resulted in the failure of the Closing to have occurred on or before the Termination Date;",
        "reference_section": "ARTICLE VII – Termination, Amendment and Waiver > Section 7.1 Termination > (b)(i)"
      }
    ],
    "hsr_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "hsr_filing_deadline",
        "answer": "25 Business Days following the date of this Agreement",
        "summary": "Each party shall make its respective filings under the HSR Act no later than twenty-five (25) Business Days following the date of this Agreement.",
        "confidence": 0.9,
        "reason": "The document specifies a deadline of twenty-five (25) Business Days for making HSR Act filings.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "second_request_deadline": [
      {
        "section": "timeline",
        "field_name": "second_request_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "cfius_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "cfius_filing_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "marketing_period_dates": [
      {
        "section": "timeline",
        "field_name": "marketing_period_dates",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "inside_date": [
      {
        "section": "timeline",
        "field_name": "inside_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "closing_date": [
      {
        "section": "timeline",
        "field_name": "closing_date",
        "answer": "third Business Day after the satisfaction or waiver of the conditions set forth in Article VI",
        "summary": "The closing date is defined as the third Business Day after the satisfaction or waiver of the conditions set forth in Article VI, unless otherwise agreed in writing by the parties.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the closing date as the third Business Day after conditions are met.",
        "clause_text": "Subject to the provisions of Article VI, the closing of the Merger (the \"Closing\") shall take place at 9:00 a.m. (Chicago, Illinois, United States time) on a date to be specified by the parties hereto, but no later than the third (3rd) Business Day after the satisfaction or waiver of the conditions set forth in Article VI (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction or waiver of such conditions), unless another time, date or place is agreed to in writing by the parties hereto (such date being the \"Closing Date\").",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.2 The Closing"
      }
    ],
    "conditions_satisfaction_end_date": [
      {
        "section": "timeline",
        "field_name": "conditions_satisfaction_end_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  }
}